|
Yitschak Barabi, Chief Financial Officer
|
|
4 Nahal Harif St., Northern Industrial Zone,
|
|
Yavne 81106, Israel
|
|
Tel: 972-8-932-1000
|
|
(Name, Telephone, E-mail and/or Facsimile number and Address of Registrant's Contact Person)
|
|
Title of each class
|
Trading symbol(s)
|
Name of each exchange on which registered
|
||
|
Ordinary Shares, NIS 0.10 par value per share
|
WILC
|
Nasdaq Capital Market
|
|
|
Large accelerated filer ☐
|
|
Accelerated filer ☐
|
|
|
|
Emerging growth company ☐
|
|
Non-accelerated filer ☒
|
|
|
Page | |
|
3 | ||
| 3 | ||
| 3 | ||
|
10 | ||
| 18 | ||
| 23 | ||
| 35 | ||
| 36 | ||
| 39 | ||
| 39 | ||
| 49 | ||
| 50 | ||
| 50 | ||
| 50 | ||
| 51 | ||
| 52 | ||
| 52 | ||
| 52 | ||
| 52 | ||
| 52 | ||
| 53 | ||
| 53 | ||
| 53 | ||
| 53 | ||
| 53 | ||
| 54 | ||
|
54 | ||
|
|
||
| 55 | ||
| 55 | ||
| 55 |
|
|
• |
payment default by, or loss of, one or more of our principal clients; the loss of one or more of our key personnel; |
|
|
• |
market risks of our portfolio of marketable securities, such as changes affecting currency exchange rates; |
|
|
• |
termination of, or changes in, arrangements with our suppliers; |
|
|
• |
increasing levels of competition in Israel and other markets in which we do business; |
|
|
• |
increase or decrease in global product prices of food products; |
|
|
• |
our inability to accurately predict consumption of our products or changes in consumer preferences; |
|
|
• |
product liability claims and other litigation matters; |
|
|
• |
interruption to our storage facilities; |
|
|
• |
our insurance coverage may not be sufficient; |
|
|
• |
our operating results may be subject to variations from quarter to quarter; |
|
|
• |
our inability to successfully compete with nationally branded products; |
|
|
• |
our inability to successfully integrate our acquisitions; |
|
|
• |
our inability to protect our intellectual property rights; |
|
|
• |
significant concentration of our shares is held by one shareholder; |
|
|
• |
we are controlled by and have business relations with Willi-Food Investments Ltd. and its management; |
|
|
• |
the price of our ordinary shares may be volatile; |
|
|
• |
our inability to meet the Nasdaq Capital Market (“Nasdaq”) and the TASE listing requirements; |
|
|
• |
our inability to obtain and maintain regulatory qualifications or approvals for our products or successfully comply with laws and
regulations related to our activities in Israel; |
|
|
• |
our inability to maintain an effective system of internal controls; |
|
|
• |
cyber-attacks on the Company's information systems; |
|
|
• |
economic conditions in Israel; |
|
|
• |
changes in political, economic and military conditions in Israel, including, in particular, economic conditions in the Company’s
core markets; and |
|
|
• |
our international operations may be adversely affected by risks associated with international business. |
|
|
• |
War, such as the current war in Israel for more information, see “– We may be affected by political, economic and military
conditions in Israel and the Middle East”. |
|
|
• |
varying regulatory restrictions on sales of our products to certain markets and unexpected changes in regulatory requirements;
|
|
|
• |
tariffs, customs, duties, quotas and other trade barriers; |
|
|
• |
global or regional economic crises; |
|
|
• |
difficulties in managing foreign operations and foreign distribution partners; |
|
|
• |
longer payment cycles and problems in collecting trade receivable; |
|
|
• |
fluctuations in currency exchange rates; |
|
|
• |
political risks; |
|
|
• |
foreign exchange controls which may restrict or prohibit repatriation of funds; |
|
|
• |
export and import restrictions or prohibitions, and delays from customs brokers or government agencies; |
|
|
• |
seasonal reductions in business activity in certain parts of the world; |
|
|
• |
potentially adverse tax consequences; and |
|
|
• |
Depending on the countries involved, any or all of the foregoing factors could materially harm our business, financial condition
and results of operations. |
| A. |
HISTORY AND DEVELOPMENT OF THE COMPANY |
| B. |
BUSINESS OVERVIEW |
|
|
• |
to promote the “Willi-Food” brand name and other brand names used by the Company (such as “Euro
European Dairies”) and to increase market penetration of products through marketing efforts and advertising campaigns; |
|
|
• |
to expand our current food product lines and diversify into additional product lines, as well as to respond
to market demand; |
|
|
• |
to enter new fields of activity/operating segments; |
|
|
• |
Expand the company's activities by improving its logistics system, including continued investment in the
construction of the new logistics center; |
|
|
• |
utilizing management’s expertise in identifying market demand and preferences, as well as its supplier sourcing abilities too;
|
|
|
• |
continue to locate, develop and distribute additional food products, some of which may be new to Israeli consumers; |
|
|
• |
penetrate new food segments within Israel through the establishment of food manufacturing factories or
the establishment of business relationships and cooperation with existing Israeli food manufacturers; |
|
|
• |
increase its inventory levels from time to time both to achieve economies of scale on its purchases from
suppliers and to more fully meet its customers’ demands; |
|
|
• |
further expand into international food markets, mainly in the U.S. and Europe, by purchasing food distribution
companies, increasing cooperation with local existing distributors and/or exporting products directly to customers; and |
|
|
• |
penetrate new markets in other countries through the establishment of business relationships and cooperation
with representatives in such markets, subject to a positive political climate. |
|
|
• |
Canned Vegetables and Pickles: including mushrooms (whole and sliced), artichoke (hearts and bottoms),
beans, asparagus, capers, corn kernels, baby corn, palm hearts, vine leaves (including vine leaves stuffed with rice), sour pickles, mixed
pickled vegetables, pickled peppers, an assortment of olives, garlic, roasted eggplant sun and dried tomatoes. These products are imported
primarily from China, Greece, Thailand, Turkey, India, and the Netherlands. |
|
|
• |
Canned Fish: including tuna (in oil or water), sardines, anchovies, smoked and pressed cod liver, herring,
fish paste and salmon. These products are primarily imported from the Philippines, Thailand, Greece, Germany and Sweden. |
|
|
• |
Canned Fruit: including pineapple (sliced or pieces), peaches, apricots, pears, cherries and fruit cocktail.
These products are primarily imported from China, Monaco, the Philippines, Thailand, Greece and Europe. |
|
|
• |
Edible Oils: including olive oil, regular and enriched sunflower oil, soybean oil, corn oil and rapeseed
oil. These products are primarily imported from Belgium, Poland, Italy, the Netherlands and Spain. |
|
|
• |
Dairy and Dairy Substitute Products: including hard and semi-hard cheeses (parmesan, edam, kashkaval, gouda,
cheddar, pecorino, manchego, maasdam, iberico and emmental), molded cheeses (Brie and Camembert), feta, Bulgarian cubes, goat cheese,
fetina, butter, butter spreads, margarine, melted cheese, cheese alternatives, condensed milk, whipped cream, yogurt, frozen pizza and
others. These products are primarily imported from Greece, France, Lithuania, Poland, Denmark, Germany, Italy and the Netherlands.
|
|
|
• |
Dried Fruit, Nuts and Beans: including figs, apricots and organic apricots, chestnuts organic chestnuts,
sunflower seeds, walnuts, pine nuts, cashews, banana chips, pistachios and peanuts. These products are primarily imported from Greece,
Turkey, India, China, Thailand and the United States. |
|
|
• |
Other Products: including, among others, instant noodle soup, frozen edamame soybeans, freeze dried instant
coffee, bagels, breadstick, coffee creamers, lemon juice, , cookies, vinegar, sweet pastry and crackers, sauces, corn flour, rice, rice
sticks, pasta, organic pasta, spaghetti and noodles, breakfast cereals, corn flakes, rusks, tortilla, dried apples snacks, deserts (such
as tiramisu and pastries) and ice cream. These products are primarily imported from the Netherlands, Germany, Italy, Greece, Belgium,
the United States, Scandinavia, Switzerland, China, Thailand, Turkey, India, and South America. |
|
|
• |
large retail supermarket chains, |
|
|
• |
small retail supermarket chains, and |
|
|
• |
other customers, including small private grocery shops, government institutions, wholesalers, restaurants,
hotels, and hospitals. |
|
Percentage of Total Sales Year Ended December 31 |
||||||||||||
|
Customer Group |
2025 |
2024 |
2023 |
|||||||||
|
Large retail supermarket chains |
55 |
% |
53 |
% |
53 |
% | ||||||
|
Small supermarket chains |
15 |
% |
15 |
% |
14 |
% | ||||||
|
Institutional market - wholesalers |
9 |
% |
10 |
% |
10 |
% | ||||||
|
Private customers |
8 |
% |
6 |
% |
6 |
% | ||||||
|
Institutional market - catering and restaurants |
7 |
% |
7 |
% |
9 |
% | ||||||
|
Government customers |
1 |
% |
3 |
% |
3 |
% | ||||||
|
Other customers |
5 |
% |
6 |
% |
5 |
% | ||||||
|
|
100 |
% |
100 |
% |
100 |
% | ||||||
|
Year ended December 31, |
||||||||||||||||
|
2025 |
2024 |
2023 |
2025 |
|||||||||||||
|
|
NIS |
NIS |
NIS |
US Dollars |
||||||||||||
|
Canned Vegetables Fruits and Pickles |
110,255 |
104,027 |
86,212 |
34,563 |
||||||||||||
|
Dairy and Dairy Substitute Products |
213,480 |
209,974 |
212,728 |
66,608 |
||||||||||||
|
Canned Fish |
86,302 |
83,056 |
74,750 |
27,367 |
||||||||||||
|
Cereals, rice and pastas |
74,577 |
59,026 |
61,573 |
23,378 |
||||||||||||
|
Oils |
47,942 |
46,727 |
43,058 |
15,029 |
||||||||||||
|
Other |
78,049 |
72,985 |
64,941 |
24,467 |
||||||||||||
|
|
• |
W.F.D. (Import, Marketing and Trading) Ltd. (“WFD”) |
|
|
• |
W. Capital Ltd. (“W. Capital”) |
|
|
• |
Euro European Dairies Ltd. |
|
|
Year Ended
December 31,
2025 |
Year Ended
December 31, 2024 |
||||||
|
Revenues |
610,605 |
575,795 |
||||||
|
Cost of Sales |
435,781 |
414,461 |
||||||
|
Gross Profit |
174,824 |
161,334 |
||||||
|
Selling Expenses |
71,721 |
68,893 |
||||||
|
General and Administrative Expenses |
28,767 |
26,165 |
||||||
|
Operating profit before other expenses (income) |
74,336 |
66,276 |
||||||
|
Other expenses (Income) |
(95 |
) |
11,402 |
) | ||||
|
Operating profit |
74,431 |
54,874 |
||||||
|
Financial Income, Net |
42,156 |
37,808 |
||||||
|
Profit before taxes on income |
116,587 |
92,682 |
||||||
|
Taxes on income |
(26,156 |
) |
(22,367 |
) | ||||
|
Net Income |
90,431 |
70,315 |
||||||
|
Name |
Age |
Position with the Company
| ||
|
Joseph Williger |
68 |
Director, and Chief Executive Officer | ||
|
Zwi Williger |
70 |
Director, Chairman of the Board | ||
|
Yitschak Barabi |
41 |
Chief Financial Officer | ||
|
Ran Asulin |
42 |
Chief Trade and Selling Officer | ||
|
Shlomo Gold |
65 |
Director | ||
|
Ayelet Nir (1) (2) |
55 |
External Director | ||
|
Idan Ben-Shitrit (1) (2) |
50 |
External Director |
|
(1) |
Member of the Audit Committee |
|
(2) |
Member of the Compensation Committee |
|
Name and Principal
Position |
Salary
(1) |
Management
Fees
(2) |
Bonus
(3) |
Options
(4) |
Total |
|
NIS thousands | |||||
|
Zwi Williger (4)
Chairman of the Board |
- |
1,518 |
2,400 |
504 |
4,423 |
|
Joseph Williger (4)
CEO and Former Co-Chairman of the Board |
- |
1,597 |
2,400 |
504 |
4,501 |
|
Yitschak Barabi
Chief Financial Officer |
805 |
- |
250 |
208 |
1,263 |
|
Ran Asulin
Chief Trade and Selling Officer |
767 |
- |
225 |
208 |
1,200 |
|
Kfir Kolp
Chief Operation Officer |
590 |
- |
81 |
84 |
755 |
|
(1) |
Includes car and mobile phone benefits. |
|
(2) |
Includes tax gross-up payments. |
|
(3)
|
Represents annual bonuses granted to the Covered Executive based on formulas set forth
in the Company’s compensation policy approved by shareholders in June 2021 and the agreements with each of the Covered Executives
which was replaced by the compensation policy approved by shareholders in June 2025. |
|
|
(a) |
Monthly service fees of NIS 108,300 (USD 33.9 thousand) (excluding VAT). |
|
|
(b) |
Profit Related Bonus - an annual bonus determined according to measurable quantitative criteria: |
|
|
(c) |
The Company will provide the Chairman/ CEO with use of a vehicle, the value of which shall not exceed NIS 400,000 (USD 125 thousand).
The Company shall allow the Chairman/ CEO to use a vehicle exceeding the value of NIS 400,000, upon the Chairman's/ CEO 's request provided
that the Chairman/ CEO will reimburse the Company with any amount exceeding NIS 400,000. The Company will cover all the operating expenses
of the Company car (excluding fines), including grossing up the related tax. The Company estimates the annual amount of the Company car
benefits in the total amount of NIS 300,000. |
|
|
(d) |
Benefits in general, including the social benefits of the Chairman/ CEO and income tax payments, national insurance payments and
other payments due to employees in respect of their employment, are to be paid for at the sole expense of the Chairman and CEO 's Management
Company. The Chairman and CEO 's Management Company has undertaken to indemnify the Company with respect to any claims against the Company
with respect to employer/employee relations. |
|
|
(e) |
The Chairman/ CEO will be included in the
D&O insurance policy available to the Company and its subsidiaries under the same terms as other officers of the Company, and he will
be entitled to an exemption and indemnification letter, which is identical to the form of exemption and indemnification that was approved
by the General Meeting of Shareholders on July 20, 2005 for all directors and officers of the Company. It is hereby clarified that the
exemption will not be valid regarding apply to any decision or transaction of the Company, in which a controlling shareholder or other
officer of the Company, (including a different officer than the officer that has been granted the exemption letter) has a personal interest.
|
|
|
1. |
Exercise Price. The exercise price of each Option is NIS 54.95 per share. |
|
|
2. |
Vesting Period. The Options will vest over a period of three (3) years, such that one-third of the total Options granted will vest
at the end of each year from the grant date. |
|
|
3. |
Exercise Period. Each vested tranche of Options may be exercised for a period of up to two (2) years from the applicable vesting
date. |
|
|
4. |
Cashless Exercise. Messrs. Zvi Williger and Yosef Williger may, at their election, exercise the Options, in whole or in part, on
a cashless basis. |
|
|
5. |
Adjustments. The Options will be subject to customary adjustments in the event of bonus share distributions, rights offerings, dividend
distributions, share splits or reverse splits, and other structural changes. |
|
|
6. |
Termination of Employment or Engagement. In the event of termination of employment or engagement, only Options that have vested as
of the termination date may be exercised. Options that have not vested as of the termination date will expire and become null and void
and will not confer any rights on their holder. Options that have vested as of the termination date may be exercised for a period of up
to sixty (60) days following the termination date or until the expiration date of such Options, whichever occurs earlier. |
|
|
1. |
Mr. Asulin’s monthly salary was increased from NIS 40,000 to NIS 45,000, effective July 1, 2025. |
|
|
2. |
Commencing July 1, 2026, Mr. Asulin’s monthly salary will be increased to NIS 50,000 (gross). |
|
|
3. |
Mr. Asulin’s monthly salary includes full social benefits, including pension contributions, severance pay and a study fund
(keren hishtalmut) contribution of 7.5% paid by the Company. |
|
|
• |
The Chairman of the board of directors; |
|
|
• |
A controlling shareholder or his relative; |
|
|
• |
Any director employed by or who provides services to the company on a regular basis; |
|
|
• |
Any director employed by the controlling shareholder or by any corporation controlled by the controlling
shareholder or who provides services to the controlling shareholder on a regular basis; and |
|
|
• |
Any director whose principal livelihood comes from the controlling shareholder. |
|
|
• |
Recommending the board of directors, the compensation policy for the company’s office holders to
be adopted by the company and to recommend to the board of directors, once every three years, regarding any extension or modification
of the current compensation policy which had been approved for a period of more than three years; |
|
|
• |
From time to time, recommending to the board of directors regarding updates required to the compensation
policy and examining the implementation thereof; |
|
|
• |
Determining whether to approve the company’s office holders’ terms of office and employment
in situations that require the approval of the compensation committee in accordance with the Israeli Companies Law; and |
|
1) |
the compensation committee and the board of directors have taken into consideration
the mandatory considerations and criteria which are specified in the Israeli Companies Law for a compensation policy and the respective
employment terms include such mandatory considerations and criteria; and |
|
2) |
the company’s shareholders approved such terms of employment, subject to a special
majority requirement. |
|
1) |
both the compensation committee and the board of directors re-discussed the transaction and decided to
approve it despite the shareholders’ objection, based on detailed reasons; and |
|
2) |
the Israeli company is not a “Public Pyramid Held Company”, which is a public company controlled
by another public company (including by a company that only issued debentures to the public), which is also controlled by another public
company (including a company that only issued debentures to the public) that has a controlling shareholder. |
|
|
• |
extraordinary transactions with a controlling shareholder or in which a controlling shareholder has a personal
interest; and |
|
|
• |
the terms of an engagement by the company, directly or indirectly, with a controlling shareholder or a
controlling shareholder’s relative (including through a corporation controlled by a controlling shareholder), regarding the company’s
receipt of services from the controlling shareholder, and if such controlling shareholder is also an office holder of the company, regarding
his or her terms of employment. |
|
|
• |
the majority of the shares of the voting shareholders who have no personal interest in the transaction
must vote in favor of the proposal (shares held by abstaining shareholders shall not be considered); or |
|
|
• |
the total shareholdings of those who have no personal interest in the transaction and who vote against
the transaction must not represent more than 2% of the aggregate voting rights in the company. |
|
1) |
such majority includes a majority of the total votes of shareholders who have no personal
interest in the approval of the transaction (and in case of a CEO, who are not a controlling shareholder) and who participate in the voting,
in person, by proxy or by written ballot, at the meeting (abstentions not taken into account); or |
|
2) |
the total number of votes of shareholders mentioned above that vote the transaction
do not represent more than 2% of the total voting rights in the company. |
|
|
• |
any amendment to the articles of association; |
|
|
• |
an increase in the company’s authorized share capital; |
|
|
• |
a merger; or |
|
|
• |
approval of actions and transactions that require shareholder approval. |
|
|
• |
each person known by the Company to beneficially own more than 5% of the outstanding shares of ordinary
shares; |
|
|
• |
each of the Company’s named executive officers and directors; and |
|
|
• |
all of the Company’s named executive officers and directors as a group. |
|
Name and Address |
Number of Ordinary Shares Beneficially Owned |
Percentage of Ordinary Shares |
||||||
|
Willi-Food Investments Ltd. (1) |
8,200,542 |
58.8 |
% | |||||
|
Joseph and Zwi Williger (1) |
173,739 |
1.25 |
% | |||||
|
Yitchak Barabi |
3,000 |
0.01 |
% | |||||
|
(1) |
As of the date hereof, ZW directly owns though a wholly-owned company 173,739 Ordinary
Shares. JW and ZW together own 100% of B.S.D shares and each be deemed to beneficially own 8,200,542 Ordinary Shares held directly by
WIL, and 173,739 Ordinary Shares held directly by ZW), or approximately 60.22% of the outstanding Ordinary Shares. Thus, as of the date
hereof, each of JW and ZW may be deemed to have the shared power to vote, or direct the voting of, and the shared power to dispose of,
or direct the disposition of, all such shares The business address of Joseph Williger is Kaplan St., Herzliya 4674311, Israel, and the
business address of Zwi Williger, 7 Hashikma St., Savion, Israel. |
|
|
• |
financial institutions or insurance companies; |
|
|
• |
real estate investment trusts, regulated investment companies or grantor trusts; |
|
|
• |
dealers or traders in securities or currencies; |
|
|
• |
tax-exempt entities; |
|
|
• |
certain former citizens or long-term residents of the United States; |
|
|
• |
persons that received our shares as compensation for the performance of services; |
|
|
• |
persons that will hold our shares as part of a “hedging” or “conversion” transaction
or as a position in a “straddle” for United States federal income tax purposes; |
|
|
• |
holders that will hold our shares through a partnership or other pass-through entity; |
|
|
• |
U.S. Holders (as defined below) whose “functional currency” is not the U.S. Dollar; or
|
|
|
• |
holders that own directly, indirectly or through attribution 10.0% or more, of the voting power or value,
of our shares. |
|
|
• |
a citizen or resident of the United States; |
|
|
• |
a corporation (or other entity treated as a corporation for United States federal income tax purposes)
created or organized in or under the laws of the United States or any state thereof, including the District of Columbia; |
|
|
• |
an estate the income of which is subject to United States federal income taxation regardless of its source;
or |
|
|
• |
a trust if such trust has validly elected to be treated as a United States person for United States federal
income tax purposes or if (1) a court within the United States is able to exercise primary supervision over its administration and (2)
one or more United States persons have the authority to control all of the substantial decisions of such trust. |
|
|
• |
such gain is effectively connected with your conduct of a trade or business in the United States; or
|
|
|
• |
you are an individual and have been present in the United States for 183 days or more in the taxable year
of such sale or exchange and certain other conditions are met. |
|
|
• |
at least 75% of its gross income is “passive income”; or |
|
|
• |
at least 50% of the average value of its gross assets (which may be determined, in part, by the market
value of our ordinary shares, which is subject to change) is attributable to assets that produce “passive income” or are held
for the production of passive income. |
|
|
Gain (loss) from exchange rate change NIS thousands |
Fair net NIS thousands |
Gain (loss) from exchange rate change NIS thousands | |||||||
|
Change in exchange rate
USD |
10%
(1,742) |
5%
(871) |
17,418 |
5%
871 |
10%
1,742 | |||||
|
Change in exchange rate
EURO |
10%
494 |
5%
247 |
(4,935) |
5%
(247) |
10%
(494) | |||||
|
|
Gain (loss) from interest change NIS thousands |
Fair value NIS thousands |
Gain (loss) from interest change NIS thousands | ||
|
Change in Interest as % of interest rate |
10% |
5% |
|
5% |
10% |
|
Increase\decrease in financial Income |
(5,650) |
(2,825) |
56,496 |
2,825 |
5,650 |
|
|
• |
pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions
and dispositions of our assets; |
|
|
• |
provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in
accordance with authorizations of our management and directors; and |
|
|
• |
provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use
or disposition of our assets that could have a material effect on the financial statements. |
|
|
NIS 2025 |
USD 2025 |
NIS 2024 |
USD 2024 |
|
Audit Fees and Tax Fees (1)(2) |
400,000 |
125,392 |
400,000 |
125,392 |
|
All Other Fees (3) |
- |
- |
- |
- |
|
TOTAL |
400,000 |
125,392 |
400,000 |
125,392 |
|
|
• |
Executive Sessions – Under Nasdaq rules,
U.S. domestic listed companies, must have a regularly scheduled meeting at which only independent directors are present. We do not have
such executive sessions. |
|
|
• |
Compensation of Officers - Under Nasdaq rules, the Company must
adopt a formal written compensation committee charter addressing the scope of the compensation committee's responsibilities, including
structure, processes and membership requirements, among others. We do not have such a formal written charter. |
|
|
• |
Nominations of Directors - Under Nasdaq rules, U.S. domestic listed
companies, must have a nominations committee comprised solely of independent directors and must have director nominees selected or recommended
by a majority of its independent directors. Our directors are not nominated in this manner. |
|
|
• |
Nominations Committee Charter or Board Resolution - Under Nasdaq
rules, U.S. domestic listed companies, must adopt a formal written charter or board resolution, as applicable, addressing the nominations
process and such related matters as may be required under the federal securities laws. We do not have such a formal written charter or
board resolution. |
|
|
• |
Quorum - Under Nasdaq rules, U.S. domestic listed company's by-laws
provide for a quorum of at least 33 1/3 percent of the outstanding shares of the company’s common voting stock. According to our
articles our quorum should be at least 25 percent of the outstanding shares of our common voting stock. |
|
|
• |
Review of Related Party Transactions: Under Nasdaq Listing Rules,
domestic listed companies must conduct an appropriate review and oversight of all related party transactions for potential conflict of
interest situations on an ongoing basis by the company’s audit committee or another independent body of the board of directors.
Although Israeli law requires us to conduct an appropriate review and maintain oversight of all related-party transactions similar to
the Nasdaq Listing Rules, we follow the definitions and requirements of the Companies Law in determining the kind of approval required
for a related-party transaction, which tend to be more rigorous than the Nasdaq Listing Rules. |
|
|
• |
Shareholder Approval of Certain Equity Compensation: Under Nasdaq
Listing Rules, shareholder approval is required prior to an issuance of securities in connection with equity-based compensation of officers,
directors, employees or consultants. The Company has indicated that it will receive shareholder approval as required by Israeli law, including
upon issuance of options to directors or to controlling shareholders. |
|
Exhibit Number
|
Description
|
|
101.INS
|
XBRL Instance Document
|
|
101.SCH
|
XBRL Taxonomy Extension Schema Document
|
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|
101.INS
|
XBRL Instance Document
|
|
†
|
Informal English translations from Hebrew original.
|
|
(1)
|
Incorporated by reference to Exhibit 1.1 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2019.
|
|
(2)
|
Incorporated by reference to Exhibit 1.2 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2019.
|
|
(3)
|
Incorporated by reference to Exhibit 2.1 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2023.
|
|
(4)
|
Incorporated by reference to Exhibit 4.8 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2005.
|
|
(5)
|
Incorporated by reference to Exhibit 4.9 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2005.
|
|
(6)
|
Incorporated by reference to Annex A to Exhibit 99.1 to the Form 6-K disseminated with the Securities and Exchange Commission, dated July 2, 2025.
|
|
(7)
|
Incorporated by reference to Exhibit 10.1 to the Company’s Registration Statement on Form S-8, File No. 333-266312.
|
|
(8)
|
Incorporated by reference to Exhibit 4.6 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2024.
|
| (9) |
Incorporated by reference to Exhibit 4.7 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2024.
|
|
(10)
|
Incorporated by reference to Exhibit 8.1 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2019.
|
|
(11)
|
Incorporated by reference to Exhibit 97.1 to the Company’s Annual Report on Form 20-F for the fiscal year ended December 31, 2023.
|
|
(*)
|
Filed Herewith
|
|
|
G. WILLI-FOOD INTERNATIONAL LTD.
By: /s/ Joseph Williger
Joseph Williger
Chief Executive Officer
|
|
Page
|
|
|
F - 3
|
|
|
(PCAOB Name: Ziv Haft Certified Public Accountants (Isr.) (#1185))
|
|
|
F - 4 - F - 5
|
|
|
F - 6
|
|
|
F - 7
|
|
|
F - 8
|
|
|
F - 9 - F - 10
|
|
|
F - 11 - F - 52
|


|
December 31,
|
||||||||||||||||
|
Note
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5 (*)
|
|
||||||||||||
|
NIS
|
NIS
|
US Dollars (in thousands)
|
||||||||||||||
|
Assets
|
||||||||||||||||
|
Current assets
|
||||||||||||||||
|
Cash and cash equivalents
|
12
|
124,158
|
122,938
|
38,921
|
||||||||||||
|
Financial assets at fair value through profit or loss
|
3
|
124,591
|
123,189
|
39,057
|
||||||||||||
|
Trade receivables, Net
|
13
|
181,762
|
171,331
|
56,979
|
||||||||||||
|
Other receivables and prepaid expenses
|
14
|
2,244
|
7,384
|
703
|
||||||||||||
|
Inventories, Net
|
15
|
94,074
|
98,234
|
29,490
|
||||||||||||
|
Current tax assets
|
10
|
1,585
|
744
|
497
|
||||||||||||
|
Total current assets
|
528,414
|
523,820
|
165,647
|
|||||||||||||
|
Non-current assets
|
||||||||||||||||
|
Property, plant, and equipment
|
201,692
|
168,217
|
63,226
|
|||||||||||||
|
Less -accumulated depreciation
|
63,468
|
58,349
|
19,896
|
|||||||||||||
|
Property, plant, and equipment, net
|
16
|
138,224
|
109,868
|
43,330
|
||||||||||||
|
Right of use assets, net
|
17
|
4,562
|
4,814
|
1,430
|
||||||||||||
|
Financial assets at fair value through profit or loss
|
3
|
49,067
|
47,842
|
15,381
|
||||||||||||
|
Goodwill
|
36
|
36
|
11
|
|||||||||||||
|
Total non-current assets
|
191,889
|
162,560
|
60,152
|
|||||||||||||
|
Total assets
|
720,303
|
686,380
|
225,799
|
|||||||||||||
|
December 31,
|
||||||||||||||||
|
Note
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5 (*)
|
|
||||||||||||
|
NIS
|
NIS
|
US Dollars (in thousands)
|
||||||||||||||
|
Equity and liabilities
|
||||||||||||||||
|
Current liabilities
|
||||||||||||||||
|
Current maturities of lease liabilities
|
17
|
2,191
|
2,179
|
687
|
||||||||||||
|
Trade payables
|
19
|
23,291
|
28,203
|
7,301
|
||||||||||||
|
Employees Benefits
|
20
|
4,861
|
4,532
|
1,524
|
||||||||||||
|
Other payables and accrued expenses
|
21
|
17,438
|
25,015
|
5,466
|
||||||||||||
|
Total current liabilities
|
47,781
|
59,929
|
14,978
|
|||||||||||||
|
Non-current liabilities
|
||||||||||||||||
|
Lease liabilities
|
17
|
2,739
|
2,521
|
859
|
||||||||||||
|
Deferred taxes
|
10
|
13,331
|
9,888
|
4,179
|
||||||||||||
|
Retirement benefit obligation
|
20, 23
|
1,361
|
1,102
|
427
|
||||||||||||
|
Total non-current liabilities
|
17,431
|
13,511
|
5,465
|
|||||||||||||
|
Shareholders' equity
|
||||||||||||||||
|
Share capital
|
22
|
1,492
|
1,491
|
467
|
||||||||||||
|
Additional paid in capital
|
174,700
|
173,062
|
54,765
|
|||||||||||||
|
Re-measurement of the net liability in respect of defined benefit
|
(256
|
)
|
(256
|
)
|
(81
|
)
|
||||||||||
|
Capital fund
|
247
|
247
|
77
|
|||||||||||||
|
Retained earnings
|
479,536
|
439,024
|
150,325
|
|||||||||||||
|
Treasury shares
|
(628
|
)
|
(628
|
)
|
(197
|
)
|
||||||||||
|
Total equity
|
655,091
|
612,940
|
205,356
|
|||||||||||||
|
Total equity and liabilities
|
720,303
|
686,380
|
225,799
|
|||||||||||||
|
Year ended December 31,
|
||||||||||||||||||||
|
Note
|
2 0 2 5
|
2 0 2 4
|
2 0 2 3
|
2 0 2 5 (*)
|
||||||||||||||||
|
NIS
|
NIS
|
NIS
|
US Dollars (in thousands)
|
|||||||||||||||||
|
Sales
|
4
|
610,605
|
575,795
|
543,262
|
191,412
|
|||||||||||||||
|
Cost of sales
|
5
|
435,781
|
414,461
|
422,695
|
136,609
|
|||||||||||||||
|
Gross profit
|
174,824
|
161,334
|
120,567
|
54,803
|
||||||||||||||||
|
Operating costs and expenses
|
||||||||||||||||||||
|
Selling expenses
|
6
|
71,721
|
68,893
|
74,216
|
22,483
|
|||||||||||||||
|
General and administrative expenses
|
7
|
28,767
|
26,165
|
26,110
|
9,018
|
|||||||||||||||
|
Operating profit before other expenses (income)
|
74,336
|
66,276
|
20,241
|
23,302
|
||||||||||||||||
|
Other expenses (Income)
|
26
|
(95
|
)
|
11,402
|
(109
|
)
|
(31
|
)
|
||||||||||||
|
Operating profit
|
74,431
|
54,874
|
20,350
|
23,333
|
||||||||||||||||
|
Finance Income
|
9
|
44,784
|
39,741
|
20,363
|
14,039
|
|||||||||||||||
|
Finance expenses
|
9
|
2,628
|
1,933
|
1,521
|
824
|
|||||||||||||||
|
Finance Income, net
|
42,156
|
37,808
|
18,842
|
13,215
|
||||||||||||||||
|
Profit before taxes on Income
|
116,587
|
92,682
|
39,192
|
36,548
|
||||||||||||||||
|
Taxes on Income
|
10
|
26,156
|
22,367
|
7,536
|
8,199
|
|||||||||||||||
|
Net Income
|
90,431
|
70,315
|
31,656
|
28,349
|
||||||||||||||||
|
Earnings per share:
|
||||||||||||||||||||
|
Basic earnings per share
|
6.50
|
5.07
|
2.28
|
2.04
|
||||||||||||||||
|
Diluted earnings per share
|
11
|
6.50
|
5.07
|
2.28
|
2.04
|
|||||||||||||||
|
Weighted average number of Shares used in computation of basic EPS
|
13,906,412
|
13,874,334
|
13,867,017
|
13,906,412
|
||||||||||||||||
|
Weighted average number of Shares used in computation of diluted EPS
|
13,913,507
|
13,874,334
|
13,867,017
|
13,913,507
|
||||||||||||||||
|
Year ended December 31,
|
||||||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 3
|
2 0 2 5 (*)
|
|
||||||||||||
|
NIS
|
NIS
|
NIS
|
US Dollars (in thousands)
|
|||||||||||||
|
Net Income
|
90,431
|
70,315
|
31,656
|
28,349
|
||||||||||||
|
Other comprehensive Income (Expenses)
|
||||||||||||||||
|
Re-measurement of net liabilities with respect to a defined benefit which will not be classified in the future as profit or loss, net of tax
|
-
|
(102
|
)
|
41
|
-
|
|||||||||||
|
Other comprehensive Income (Expenses) for the year
|
-
|
(102
|
)
|
41
|
-
|
|||||||||||
|
Total comprehensive Income for the year
|
90,431
|
70,213
|
31,697
|
28,349
|
||||||||||||
|
Share capital
|
Additional paid in capital
|
Re-Measurement of the net liability in respect of defined benefit
|
Capital fund
|
Retained earnings
|
Treasury
shares
|
Total shareholders' equity
|
||||||||||||||||||||||
|
Balance – January 1, 2023
|
1,490
|
171,550
|
(195
|
)
|
247
|
386,980
|
(628
|
)
|
559,444
|
|||||||||||||||||||
|
Profit for the year
|
-
|
-
|
-
|
-
|
31,656
|
-
|
31,656
|
|||||||||||||||||||||
|
Measurement of the net liability in respect of defined benefit
|
-
|
-
|
41
|
-
|
-
|
-
|
41
|
|||||||||||||||||||||
|
Total comprehensive Income for the year
|
-
|
-
|
41
|
-
|
31,656
|
-
|
31,697
|
|||||||||||||||||||||
|
Share based payment
|
-
|
1,039
|
-
|
-
|
-
|
-
|
1,039
|
|||||||||||||||||||||
|
Dividend distribution
|
-
|
-
|
-
|
-
|
(39,945
|
)
|
-
|
(39,945
|
)
|
|||||||||||||||||||
|
Balance – December 31, 2023
|
1,490
|
172,589
|
(154
|
)
|
247
|
378,691
|
(628
|
)
|
552,235
|
|||||||||||||||||||
|
Profit for the year
|
-
|
-
|
-
|
-
|
70,315
|
-
|
70,315
|
|||||||||||||||||||||
|
Measurement of the net liability in respect of defined benefit
|
-
|
-
|
(102
|
)
|
-
|
-
|
-
|
(102
|
)
|
|||||||||||||||||||
|
Total comprehensive Income for the year
|
-
|
-
|
(102
|
)
|
-
|
70,315
|
-
|
70,213
|
||||||||||||||||||||
|
Share based payment
|
-
|
473
|
-
|
-
|
-
|
-
|
473
|
|||||||||||||||||||||
|
Conversion of share based payment options
|
1
|
-
|
-
|
-
|
-
|
-
|
1
|
|||||||||||||||||||||
|
Dividend distribution
|
-
|
-
|
-
|
-
|
(9,982
|
)
|
-
|
(9,982
|
)
|
|||||||||||||||||||
|
Balance – December 31, 2024
|
1,491
|
173,062
|
(256
|
)
|
247
|
439,024
|
(628
|
)
|
612,940
|
|||||||||||||||||||
|
Profit for the year
|
-
|
-
|
-
|
-
|
90,431
|
-
|
90,431
|
|||||||||||||||||||||
|
Measurement of the net liability in respect of defined benefit
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
|||||||||||||||||||||
|
Total comprehensive Income for the year
|
-
|
-
|
-
|
-
|
90,431
|
-
|
90,431
|
|||||||||||||||||||||
|
Share based payment
|
-
|
1,639
|
-
|
-
|
-
|
-
|
1,639
|
|||||||||||||||||||||
|
Conversion of share based payment options
|
1
|
(1
|
)
|
-
|
-
|
-
|
-
|
-
|
||||||||||||||||||||
|
Dividend distribution
|
-
|
-
|
-
|
-
|
(49,919
|
)
|
-
|
(49,919
|
)
|
|||||||||||||||||||
|
Balance – December 31, 2025
|
1,492
|
174,700
|
(256
|
)
|
247
|
479,536
|
(628
|
)
|
655,091
|
|||||||||||||||||||
|
Year ended December 31,
|
||||||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 3
|
2 0 2 5 (*)
|
|||||||||||||
|
NIS
|
NIS
|
NIS
|
US Dollars (in thousands)
|
|||||||||||||
|
CASH FLOWS – OPERATING ACTIVITIES
|
||||||||||||||||
|
Profit from continuing operations
|
90,431
|
70,315
|
31,656
|
28,349
|
||||||||||||
|
Adjustments to reconcile net profit to net cash provided (used in) continuing operating activities (Appendix A)
|
(31,630
|
)
|
(27,342
|
)
|
2,052
|
(9,916
|
)
|
|||||||||
|
Net cash from operating activities
|
58,801
|
42,973
|
33,708
|
18,433
|
||||||||||||
|
Cash flows – investing activities
|
||||||||||||||||
|
Acquisition of property plant and equipment
|
(5,801
|
)
|
(5,414
|
)
|
(4,605
|
)
|
(1,818
|
)
|
||||||||
|
Acquisition of property plant and equipment under construction
|
(28,172
|
)
|
(43,332
|
)
|
(18,941
|
)
|
(8,833
|
)
|
||||||||
|
Proceeds from sale of property plant and Equipment
|
95
|
552
|
208
|
31
|
||||||||||||
|
Proceeds from sale (purchase) of marketable securities, net
|
29,750
|
2,482
|
18,166
|
9,326
|
||||||||||||
|
Net cash used in investing activities
|
(4,128
|
)
|
(45,712
|
)
|
(5,172
|
)
|
(1,294
|
)
|
||||||||
|
Cash flows – financing activities
|
||||||||||||||||
|
Lease liability payments
|
(1,879
|
)
|
(2,322
|
)
|
(2,408
|
)
|
(589
|
)
|
||||||||
|
Dividend distribution
|
(49,919
|
)
|
(9,982
|
)
|
(39,945
|
)
|
(15,649
|
)
|
||||||||
|
Net cash used in financing activities
|
(51,798
|
)
|
(12,304
|
)
|
(42,353
|
)
|
(16,238
|
)
|
||||||||
|
Increase (decrease) in cash and cash equivalents
|
2,875
|
(15,043
|
)
|
(13,817
|
)
|
901
|
||||||||||
|
Cash and cash equivalents at the beginning of the financial year
|
122,938
|
137,466
|
150,607
|
38,539
|
||||||||||||
|
Exchange gains (losses) on cash and cash equivalents
|
(1,655
|
)
|
515
|
676
|
(519
|
)
|
||||||||||
|
Cash and cash equivalents of the end of the financial year
|
124,158
|
122,938
|
137,466
|
38,921
|
||||||||||||
|
Year ended December 31,
|
||||||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 3
|
2 0 2 5 (*)
|
|||||||||||||
|
NIS
|
NIS
|
NIS
|
US Dollars (in thousands)
|
|||||||||||||
|
Cash flows from/ (used in) operating activities
|
||||||||||||||||
|
A. Adjustments to reconcile net profit to net cash from operating activities
|
||||||||||||||||
|
Increase in deferred income taxes
|
3,443
|
5,020
|
670
|
1,079
|
||||||||||||
|
Unrealized gain on marketable securities
|
(32,377
|
)
|
(25,207
|
)
|
(5,597
|
)
|
(10,150
|
)
|
||||||||
|
Depreciation and amortization
|
5,617
|
(**) 5,177
|
(**) 4,546
|
|
1,761
|
|||||||||||
|
Depreciation expense on right-to-use assets
|
2,361
|
(**) 2,125
|
|
(**) 2,404
|
|
740
|
||||||||||
|
Capital gain on disposal of property plant and equipment
|
(95
|
)
|
(263
|
)
|
(109
|
)
|
(31
|
)
|
||||||||
|
Exchange losses (gains) on cash and cash equivalents
|
1,655
|
(515
|
)
|
(676
|
)
|
519
|
||||||||||
|
Share based payment
|
1,639
|
473
|
1,039
|
514
|
||||||||||||
|
Changes in assets and liabilities:
|
||||||||||||||||
|
Decrease in trade receivables and other receivables
|
17,212
|
18,047
|
7,527
|
5,396
|
||||||||||||
|
Decrease (Increase) in inventories
|
4,160
|
(35,759
|
)
|
9,454
|
1,304
|
|||||||||||
|
Increase (decrease) in trade payables, other payables and other current liabilities
|
(11,901
|
)
|
21,026
|
(3,547
|
)
|
(3,730
|
)
|
|||||||||
|
Cash generated from operations
|
(8,286
|
)
|
(9,876
|
)
|
15,711
|
(2,598
|
)
|
|||||||||
|
Income tax paid
|
(23,344
|
)
|
(17,466
|
)
|
(13,659
|
)
|
(7,318
|
)
|
||||||||
|
Net cash provided by (used in) operating activities
|
(31,630
|
)
|
(27,342
|
)
|
2,052
|
(9,916
|
)
|
|||||||||
|
The Company was incorporated in Israel in January 1994 under the name G. Willi-Food Ltd. and commenced operations in February 1994. It changed its name to G. Willi-Food International Ltd. on June 1996. The Company's corporate headquarters and principal executive offices are located at 4 Nahal Harif Street, Northern Industrial Zone, Yavne 81106, Israel.
The Company completed its IPO in the United States in May 1997, at which time its ordinary shares began trading on the Nasdaq Capital Market, where they currently trade under the symbol “WILC”. On June 15, 2020, our ordinary shares began trading on the Tel Aviv Stock Exchange under the symbol “WILF”.
The Company is an Israeli-based company specializing in high-quality, great-tasting kosher food products. The Company is engaged, directly and through subsidiaries, in the design, import, marketing and distribution of a wide variety of over 650 food products worldwide. In the three years that ended on December 31, 2025, substantially all our revenue was generated in Israel, with less than 1% of our revenue resulting from exports outside Israel.
The Company purchases food products from over 125 suppliers located in Israel and throughout the world, including from the Far East (China, India, the Philippines Thailand and Vietnam), Eastern Europe (Poland, Lithuania, Bosnia and Latvia), South America (Ecuador and Peru), Western and Central Europe (the Netherlands, Belgium, Germany, Austria, Sweden, Switzerland, Denmark, and France) and Southern Europe (Spain, Italy, Turkey and Greece) and more.
The Company's products are marketed and sold to approximately 1,500 customers and 3,000 selling points in Israel, including to supermarket chains, wholesalers and institutional consumers. The Company markets most of its products under the brand name “Willi-Food,” and most of its chilled and frozen products under the brand name “Euro European Dairies”. Certain products are marketed under brand names of other manufacturers or under other brand names.
|
F - 11
|
Note 1 – Basis of preparation (continued)
|
|
Following changes in management in recent years, the Company continues to re-evaluate its strategic position and consider other business opportunities. As part of this re-evaluation, the Company is considering forming strategic alliances with or entering into different lines of business, expanding its product lines, and increasing product sales with existing customers while adding new customers. In addition, the Company is examining M&A opportunities to further increase its market presence.
As of March, 24, 2026, the Company’s principal shareholder, Willi-Food Investments Ltd, held approximately 58.8% of our ordinary shares.
|
|
The principal accounting policies adopted in the preparation of the consolidated financial statements are set out in note 27. The policies have been consistently applied to all the years presented, unless otherwise stated.
|
|
The consolidated financial statements are presented in New Israeli Shekels (NIS), which is also the Company functional currency.
|
|
The translation from New Israeli Shekels (NIS) into U.S. dollars was made at the exchange rate as of December 31, 2025, on which USD 1.00 equaled NIS 3.190 The use of USD is solely for the convenience of the reader.
|
|
These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards and International Accounting Standards as issued by the International Accounting Standards Board (IASB) and Interpretations (collectively IFRSs).
|
|
The preparation of financial statements in compliance with adopted IFRS requires the use of certain critical accounting estimates. It also requires Company management to exercise judgment in applying the Company's accounting policies. The areas where significant judgments and estimates have been made in preparing the consolidated financial statements and their effect are disclosed in note 2.
|
|
Basis of measurement:
|
|
The consolidated financial statements have been prepared on a historical cost basis, except for the following items (refer to individual accounting policies for details):
|
|
- Financial instruments – fair value through profit or loss
|
|
- Net defined benefit liability
|
F - 12
|
Note 1 – Basis of preparation (continued)
|
|
Changes in accounting policies
|
|
A. New standards, interpretations and amendments adopted from 1 January, 2025:
|
|
The following amendments are effective for the period beginning 1 January 2025:
|
|
- Lack of exchangeability (Amendment to IAS 21 The Effects of Changes in Foreign Exchange Rates).
|
|
On 15 August 2023, the IASB issued Lack of Exchangeability which amended IAS 21 The Effects of Changes in Foreign Exchange Rates (the Amendments). The Amendments introduce requirements to assess when a currency is exchangeable into another currency and when it is not. The Amendments require an entity to estimate the spot exchange rate when it concludes that a currency is not exchangeable into another currency.
|
|
These amendments had no effect on the consolidated financial statements of the Company.
|
|
The following illustrative examples have been issued during 2025 with no effective date:
|
|
- Illustrative examples on reporting uncertainties in financial statements.
|
|
On 28 November 2025, the IASB issued Disclosures about Uncertainties in the Financial Statements – Illustrative examples, which amended multiple IFRS Accounting Standards to include illustrative examples demonstrating how companies can apply IFRS Accounting Standards when reporting the effects of uncertainties in their financial statements. The illustrative examples are accompanying materials to IFRS Accounting Standards and do not have an effective date. The IASB had issued a near-final staff draft of the illustrative examples in July 2025. The Company has considered these illustrative examples in its preparation of the consolidated financial statements and no additional disclosures or changes in presentation were considered necessary.
|
F - 13
|
Note 1 – Basis of preparation (continued)
|
|
Changes in accounting policies (continued)
|
|
B. New standards, interpretations and amendments not yet effective
|
|
There are a number of standards, amendments to standards, and interpretations which have been issued by the IASB that are effective in future accounting periods that the Company has decided not to adopt early.
|
|
The following standards and amendments are effective for the annual reporting period beginning 1 January 2027:
|
|
- IFRS 18 Presentation and Disclosure in Financial Statements
|
|
- IFRS 19 Subsidiaries without Public Accountability: Disclosures.
|
|
The Company is currently assessing the effect of these new accounting standards and amendments.
|
|
IFRS 18 Presentation and Disclosure in Financial Statements, which was issued by the IASB in April 2024 supersedes IAS 1 and will result in major consequential amendments to IFRS Accounting Standards including IAS 8 Basis of Preparation of Financial Statements (renamed from Accounting Policies, Changes in Accounting Estimates and Errors). Even though IFRS 18 will not have any effect on the recognition and measurement of items in the consolidated financial statements, it is expected to have a significant effect on the presentation and disclosure of certain items. These changes include categorization and sub-totals in the statement of profit or loss, aggregation/disaggregation and labelling of information, and disclosure of management-defined performance measures.
|
|
The Company does not expect to be eligible to apply IFRS 19.
|
F - 14
|
The Company makes certain estimates and assumptions regarding the future. Estimates and judgements are continually evaluated based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. In the future, actual experience may differ from these estimates and assumptions. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are discussed below.
|
|
Estimates and assumptions:
|
|
- Fair value measurement
several assets included in the Company’s financial and non-financial assets utilizes market observables inputs and data as far as possible. Inputs used in determining fair value measurement are categorized into different levels based on how observable the inputs used in the valuation technique utilized are (the 'fair value hierarchy'):
• Level 1: Quoted priced in active markets for identical items (unadjusted)
• Level 2: Observable direct or indirect inputs other than level 1 inputs.
• Level 3: Unobservable inputs (i.e., not derived from market data).
The classification of an item into the above levels is based on the lowest level of the inputs used that has a significant effect on the fair value measurement of the item. Transfers of items between levels are recognized in the period they occur.
|
|
The Company measures part of its financial instruments at fair value:
|
|
- Current financial assets at fair value through profit or loss (see note 3)
|
|
- Non-current financial assets at fair value through profit or loss (see note 3)
|
F - 15
|
The Company is exposed through its operations to the following financial risks:
|
|
- Credit risk
|
|
- Other market price risk
|
|
- Foreign exchange risk
|
|
- Global changes in raw-material prices
|
|
In common with all other businesses, the Company is exposed to risks that arise from its use of financial instruments. This note describes the Company's objectives, policies and processes for managing those risks and the methods used to measure them. Further quantitative information in respect of these risks is presented throughout these financial statements.
|
|
There have been no substantive changes in the Company's exposure to financial instrument risks, its objectives, policies and processes for managing those risks or the methods used to measure them from previous periods unless otherwise stated in this note.
|
|
(i) Principal financial instruments
|
|
The principal financial instruments used by the Company, from which financial instrument risk arises, are as follows:
|
|
- Cash and cash equivalents
|
|
- Trade and other receivables
|
|
- Financial assets at fair value through profit or loss
|
|
- Lease liabilities
|
|
- Trade payables
|
|
(ii) Financial instruments by category
|
|
Financial assets:
|
|
Fair value through profit or loss
|
Amortized cost
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
NIS in thousands
|
||||||||||||||||
|
Cash and cash equivalents
|
-
|
-
|
124,158
|
122,938
|
||||||||||||
|
Financial assets at fair value through profit or loss
|
173,658
|
171,031
|
-
|
-
|
||||||||||||
|
Trade and other receivables
|
-
|
-
|
184,006
|
178,715
|
||||||||||||
|
Total financial assets
|
173,658
|
171,031
|
308,164
|
301,653
|
||||||||||||
F - 16
|
Note 3 – Financial instruments risk management (continued)
(ii) Financial instruments by category (continued)
|
|
Financial liabilities:
|
|
Amortized cost
|
||||||||
|
2025
|
2024
|
|||||||
|
NIS in thousands
|
||||||||
|
Trade payables
|
23,291
|
28,203
|
||||||
|
Lease liabilities
|
4,930
|
4,700
|
||||||
|
Total financial liabilities
|
28,221
|
32,903
|
||||||
|
(iii) Financial instruments not measured at fair value
|
|
Financial instruments not measured at fair value includes cash and cash equivalents, loans to others, trade and other receivables and trade payables.
|
|
Due to their short-term nature, the carrying value of cash and cash equivalents, loans to others, trade and other receivables, and trade payables approximates their fair value.
|
|
(iv) Financial instruments measured at fair value
|
|
The fair value hierarchy of financial instruments measured at fair value is provided below
|
|
Level 1
|
Level 2
|
Level 3
|
||||||||||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||||||||
|
NIS in thousands
|
||||||||||||||||||||||||
|
Financial assets at fair value through profit or loss
|
124,591
|
123,189
|
-
|
-
|
49,067
|
47,842
|
||||||||||||||||||
|
There were no transfers between levels during the period.
|
|
There were not any changes with the valuation techniques and significant unobservable inputs used in determining the fair value during the period.
|
|
The fair value of the investment in non-tradable participation units is calculated using the asset value method.
|
F - 17
|
Note 3 – Financial instruments risk management (continued)
(iv) Financial instruments measured at fair value (continued)
|
|
The reconciliation of the opening and closing fair value balance of financial instruments is provided below:
|
|
Financial assets at fair value through profit or loss:
|
Level 1
|
Level 3
|
||||||
|
NIS in thousands
|
||||||||
|
January 1, 2025
|
123,189
|
(*) 47,842
|
|
|||||
|
Purchases
|
45,304
|
1,000
|
||||||
|
Disposals
|
(76,054
|
)
|
-
|
|||||
|
Gain (Loss)
|
32,152
|
225
|
||||||
|
December 31, 2025
|
124,591
|
49,067
|
||||||
|
General objectives, policies and processes
|
|
Credit risk
|
|
Credit risk is the risk of financial loss to the Company if a customer or counterparty to a financial instrument fails to meet its contractual obligations. The Company is mainly exposed to credit risk from credit sales. It is Company policy, implemented locally, to assess the credit risk of new customers before entering contracts. Such credit ratings are taken into account by local business practices.
|
|
The Company has established a credit policy under which each new customer is analyzed individually for creditworthiness before the Company's standard payment and delivery terms and conditions are offered. The Company's review includes external ratings, when available, and in some cases bank references. Purchase limits are established for each customer, which represents the maximum open amount.
|
F - 18
|
Note 3 – Financial instruments risk management (continued)
|
|
Other market price risk
|
|
The Company is exposed to price risks of shares, certificate of participation in mutual fund and bonds, which are classified as financial assets carried at fair value through profit or loss.
|
|
The effect of a 10% increase in the value of the portfolio securities investment held at the reporting date would, if all other variables held constant, have resulted in an increase in the fair value through profit or loss and net assets of NIS 9,881 thousand (2024: NIS 14,431 thousand). A 10% decrease in their value would, on the same basis, have decreased the fair value through other profit or loss reserve and net assets by the same amount.
|
|
Foreign exchange risk
|
|
Foreign exchange risk arises when the Company enters into transactions denominated in a currency other than its functional currency. The Company buys its inventories mostly in USD and EURO and sells its products in NIS. Foreign exchange exposures are managed within utilizing forward foreign exchange contracts.
|
|
As of December 31, the Company's net exposure to foreign exchange risk was as follows:
|
|
2025
|
2024
|
|||||||
|
Net foreign currency
financial assets/(liabilities)
|
NIS in thousands
|
|||||||
|
US Dollars
|
17,418
|
20,323
|
||||||
|
EURO
|
(4,935
|
)
|
2,560
|
|||||
|
Total net exposure
|
12,483
|
22,883
|
||||||
|
The following table details the Company's sensitivity to a 10% increase and decrease in the NIS against the relevant foreign currencies. 10% is the sensitivity rate used when reporting foreign currency risk internally to key management personnel and represents management's assessment of the reasonably possible change in foreign exchange rates. The sensitivity analysis includes only outstanding foreign currency denominated monetary items and adjusts their translation at the period end for a 10% change in foreign currency rates. A positive number below indicates an increase in profit and other equity where the NIS strengthens 10% against the relevant currency. For a 10% weakening of the NIS against the relevant currency, there would be opposite impact on the profit and other equity, and the balances below would be negative.
|
|
US Dollars
|
EURO
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
NIS in thousands
|
||||||||||||||||
|
10% increase
|
1,742
|
2,032
|
(494
|
)
|
256
|
|||||||||||
|
10% decrease
|
(1,742
|
)
|
(2,032
|
)
|
494
|
(256
|
)
|
|||||||||
F - 19
|
Note 3 – Financial instruments risk management (continued)
|
|
Global changes in raw-material prices
|
|
Raw material prices are mainly affected by weather fluctuations affecting agricultural crops, crude oil prices, accelerated growth and growing demand in developing countries affecting world consumption, rise in living standards mainly in developing countries and speculative transactions in the commodity market. A possible rise in the price of raw materials may lead to higher prices for products by suppliers. Sharp price increases in commodity prices may have a material adverse effect on the Company's operations and business results.
|
|
The Company has one reportable segment:
|
|
- Import- export, marketing and distribution of food products.
|
|
Factors that management used to identify the Company's reportable segments
|
|
The Company's reportable segments are strategic business units that offer different products and services. They are managed separately because each business requires different marketing strategies.
|
|
Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating decision maker has been identified as the management team including the Chief Executive Officer, and the co-chairman of the board of directors.
|
|
The table below shows the Company's revenues from major groups of products that contributed 10% or more to the Company's total revenues in the years 2023 to 2025:
|
|
Year ended December 31,
|
||||||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 3
|
2 0 2 5
|
|||||||||||||
|
NIS
|
NIS
|
NIS
|
US Dollars
|
|||||||||||||
|
Dairy and Dairy Substitute Products
|
213,480
|
209,974
|
212,728
|
66,608
|
||||||||||||
|
Canned Vegetables, Fruits and Pickles
|
110,255
|
104,027
|
(*) 86,212
|
|
34,563
|
|||||||||||
|
Canned Fish
|
86,302
|
83,056
|
74,750
|
27,367
|
||||||||||||
|
Cereals, rice and pastas
|
74,577
|
59,026
|
61,573
|
23,378
|
||||||||||||
|
Oils
|
47,942
|
46,727
|
43,058
|
15,029
|
||||||||||||
|
Other
|
78,049
|
72,985
|
(*) 64,941
|
|
24,467
|
|||||||||||
|
610,605
|
575,795
|
543,262
|
191,412
|
|||||||||||||
F - 20
|
Note 4 – Segment information (continued)
|
|
Revenues by customer group
|
|
Percentage of Total Sales
Year ended December 31,
|
||||||||||||
|
2 0 2 5
|
(*)2024
|
(*)2023
|
||||||||||
|
Large retail supermarket chains
|
55
|
%
|
53
|
%
|
53
|
%
|
||||||
|
Small supermarket chains
|
15
|
%
|
15
|
%
|
14
|
%
|
||||||
|
Institutional market - wholesalers
|
9
|
%
|
10
|
%
|
10
|
%
|
||||||
|
Private customers
|
8
|
%
|
6
|
%
|
6
|
%
|
||||||
|
Institutional market - catering and restaurants
|
7
|
%
|
7
|
%
|
9
|
%
|
||||||
|
Government customers
|
1
|
%
|
3
|
%
|
3
|
%
|
||||||
|
Other customers
|
5
|
%
|
6
|
%
|
5
|
%
|
||||||
|
100
|
%
|
100
|
%
|
100
|
%
|
|||||||
|
Revenues from main customers of the Import segment
|
|
The Company has one customer who represented more than 10% of the total sales which amounted to NIS 65,084 thousand in 2025 (2024: NIS 51,371 thousand 2023: NIS 60,431 thousand).
|
|
Year ended December 31,
|
||||||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 3
|
2 0 2 5
|
|||||||||||||
|
NIS
|
NIS
|
NIS
|
US Dollars
|
|||||||||||||
|
Purchases
|
379,700
|
391,931
|
377,013
|
119,028
|
||||||||||||
|
Marine transportation
|
21,507
|
22,888
|
17,039
|
6,742
|
||||||||||||
|
Maintenance
|
5,063
|
5,789
|
(*) 5,585
|
|
1,587
|
|||||||||||
|
External Storage
|
8,477
|
5,012
|
(*) 4,930
|
|
2,657
|
|||||||||||
|
Transportation
|
4,280
|
3,830
|
3,120
|
1,342
|
||||||||||||
|
Salaries and related expenses
|
3,092
|
3,145
|
2,800
|
969
|
||||||||||||
|
Depreciation and amortization
|
3,324
|
2,951
|
2,562
|
1,042
|
||||||||||||
|
Packing materials
|
2,621
|
2,881
|
1,746
|
822
|
||||||||||||
|
Personnel services
|
2,611
|
1,030
|
-
|
819
|
||||||||||||
|
Outsourced packing
|
26
|
641
|
3,195
|
8
|
||||||||||||
|
Other costs and expenses
|
3,565
|
3,387
|
3,101
|
1,118
|
||||||||||||
|
434,266
|
443,485
|
421,091
|
136,134
|
|||||||||||||
|
Changes in inventories of finished products
|
1,515
|
(29,024
|
)
|
1,604
|
475
|
|||||||||||
|
435,781
|
414,461
|
422,695
|
136,609
|
|||||||||||||
F - 21
|
Year ended December 31,
|
||||||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 3
|
2 0 2 5
|
|||||||||||||
|
NIS
|
NIS
|
NIS
|
US Dollars
|
|||||||||||||
|
Transportation and Distribution
|
24,377
|
23,425
|
22,048
|
7,642
|
||||||||||||
|
Salaries and related expenses
|
23,759
|
22,954
|
22,728
|
7,448
|
||||||||||||
|
Advertising and promotion
|
7,399
|
8,297
|
11,923
|
2,319
|
||||||||||||
|
Personnel services
|
4,073
|
3,963
|
4,388
|
1,277
|
||||||||||||
|
Vehicles
|
4,525
|
3,690
|
3,793
|
1,418
|
||||||||||||
|
Depreciation and amortization
|
2,719
|
2,600
|
2,923
|
852
|
||||||||||||
|
Share based payment expense
|
371
|
178
|
435
|
116
|
||||||||||||
|
Others
|
4,498
|
3,786
|
5,978
|
1,411
|
||||||||||||
|
71,721
|
68,893
|
74,216
|
22,483
|
|||||||||||||
|
Year ended December 31,
|
||||||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 3
|
2 0 2 5
|
|||||||||||||
|
NIS
|
NIS
|
NIS
|
US Dollars
|
|||||||||||||
|
Salaries and related expenses
|
20,950
|
17,397
|
16,598
|
6,568
|
||||||||||||
|
Professional services
|
1,912
|
2,675
|
2,471
|
599
|
||||||||||||
|
Office maintenance
|
1,505
|
1,764
|
1,667
|
472
|
||||||||||||
|
Depreciation and amortization
|
1,935
|
1,751
|
1,465
|
607
|
||||||||||||
|
Vehicles
|
467
|
634
|
507
|
146
|
||||||||||||
|
Share based payment expense
|
1,268
|
295
|
604
|
398
|
||||||||||||
|
Communication
|
67
|
74
|
94
|
21
|
||||||||||||
|
Bad and doubtful debts
|
(643
|
)
|
(426
|
)
|
(46
|
)
|
(202
|
)
|
||||||||
|
Other
|
1,306
|
2,001
|
2,750
|
409
|
||||||||||||
|
28,767
|
26,165
|
26,110
|
9,018
|
|||||||||||||
F - 22
|
Key management personnel compensation
|
|
Key management personnel are those persons having authority and responsibility for planning, directing and controlling the activities of the Company, including the directors of the company and other senior officers.
Key management personnel expenses comprise:
|
|
Year ended December 31,
|
||||||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 3
|
2 0 2 5
|
|||||||||||||
|
NIS
|
NIS
|
NIS
|
US Dollars
|
|||||||||||||
|
Salary and management fees
|
5,312
|
6,286
|
6,021
|
1,665
|
||||||||||||
|
Bonus
|
5,356
|
3,259
|
2,661
|
1,679
|
||||||||||||
|
Share based payment expense
|
1,509
|
249
|
536
|
473
|
||||||||||||
|
Directors' remuneration
|
245
|
215
|
228
|
77
|
||||||||||||
|
12,422
|
10,009
|
9,446
|
3,894
|
|||||||||||||
|
Year ended December 31,
|
||||||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 3
|
2 0 2 5
|
|||||||||||||
|
Finance income:
|
NIS
|
NIS
|
NIS
|
US Dollars
|
||||||||||||
|
Interest from Short-term bank deposits
|
4,237
|
4,258
|
4,644
|
1,328
|
||||||||||||
|
Dividends
|
4,241
|
5,378
|
5,201
|
1,329
|
||||||||||||
|
Changes in fair value of financial assets at fair values
|
31,899
|
(*) 23,802
|
|
3,567
|
10,000
|
|||||||||||
|
Income from revaluation of a long-term financial assets
|
1,143
|
(*) 2,049
|
|
2,030
|
358
|
|||||||||||
|
Foreign currency differences
|
-
|
367
|
676
|
-
|
||||||||||||
|
Interest Income of debentures held for trading
|
3,141
|
3,811
|
4,207
|
985
|
||||||||||||
|
Other interest
|
123
|
76
|
38
|
39
|
||||||||||||
|
Total finance income
|
44,784
|
39,741
|
20,363
|
14,039
|
||||||||||||
|
Year ended December 31,
|
||||||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 3
|
2 0 2 5
|
|||||||||||||
|
Finance expenses:
|
NIS
|
NIS
|
NIS
|
US Dollars
|
||||||||||||
|
Bank fees
|
525
|
586
|
535
|
165
|
||||||||||||
|
Portfolio management fees
|
587
|
1,107
|
204
|
184
|
||||||||||||
|
Foreign currency differences
|
1,181
|
-
|
-
|
370
|
||||||||||||
|
Other
|
335
|
240
|
782
|
105
|
||||||||||||
|
Total finance expenses
|
2,628
|
1,933
|
1,521
|
824
|
||||||||||||
F - 23
|
Tax balances presented in the statement of financial position:
|
|
December 31,
|
||||||||||||
|
2025
|
2024
|
2025
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Current tax assets
|
1,585
|
744
|
497
|
|||||||||
|
Deferred tax liabilities
|
(13,331
|
)
|
(9,888
|
)
|
(4,179
|
)
|
||||||
|
January
|
December
|
December
|
||||||||||||||
|
1, 2025
|
Change
|
31, 2025
|
31, 2025
|
|||||||||||||
|
NIS
|
NIS
|
NIS
|
US Dollars
|
|||||||||||||
|
Deferred taxes arise from the following:
|
||||||||||||||||
|
Financial assets carried at fair value through profit or loss
|
(10,819
|
)
|
(3,293
|
)
|
(14,112
|
)
|
(4,424
|
)
|
||||||||
|
Leases
|
27
|
12
|
39
|
12
|
||||||||||||
|
Employees benefits
|
521
|
86
|
607
|
190
|
||||||||||||
|
Allowance of credit loss
|
219
|
(134
|
)
|
85
|
27
|
|||||||||||
|
Carry forward tax losses
|
164
|
(114
|
)
|
50
|
16
|
|||||||||||
|
(9,888
|
)
|
(3,443
|
)
|
(13,331
|
)
|
(4,179
|
)
|
|||||||||
|
January
|
December
|
December
|
||||||||||||||
|
1, 2024
|
Change
|
31, 2024
|
31, 2024
|
|||||||||||||
|
NIS
|
NIS
|
NIS
|
US Dollars
|
|||||||||||||
|
Deferred taxes arise from the following:
|
||||||||||||||||
|
Financial assets carried at fair value through profit or loss
|
(5,845
|
)
|
(4,974
|
)
|
(10,819
|
)
|
(3,392
|
)
|
||||||||
|
Leases
|
19
|
8
|
27
|
8
|
||||||||||||
|
Employees benefits
|
501
|
20
|
521
|
163
|
||||||||||||
|
Allowance of credit loss
|
317
|
(98
|
)
|
219
|
69
|
|||||||||||
|
Carry forward tax losses
|
140
|
24
|
164
|
52
|
||||||||||||
|
(4,868
|
)
|
(5,020
|
)
|
(9,888
|
)
|
(3,100
|
)
|
|||||||||
|
Year ended December 31,
|
||||||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 3
|
2 0 2 5
|
|||||||||||||
|
NIS
|
NIS
|
NIS
|
US Dollars
|
|||||||||||||
|
Current taxes:
|
||||||||||||||||
|
Current taxes
|
22,713
|
17,347
|
6,866
|
7,120
|
||||||||||||
|
22,713
|
17,347
|
6,866
|
7,120
|
|||||||||||||
|
Change in deferred taxes
|
3,443
|
5,020
|
670
|
1,079
|
||||||||||||
|
26,156
|
22,367
|
7,536
|
8,199
|
|||||||||||||
F - 24
|
Reconciliation of the statutory tax rate to the effective tax rate:
|
|
Year ended December 31,
|
||||||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 3
|
2 0 2 5
|
|||||||||||||
|
NIS
|
NIS
|
NIS
|
US Dollars
|
|||||||||||||
|
Income before Income taxes
|
116,587
|
92,682
|
39,192
|
36,548
|
||||||||||||
|
Statutory tax rate
|
23
|
%
|
23
|
%
|
23
|
%
|
23
|
%
|
||||||||
|
Tax computed by statutory tax rate
|
26,815
|
21,317
|
9,014
|
8,405
|
||||||||||||
|
Tax increments (savings) due to:
|
||||||||||||||||
|
Non-deductible expenses
|
451
|
2,515
|
541
|
141
|
||||||||||||
|
Temporary differences
|
(39
|
)
|
(27
|
)
|
(19
|
)
|
(12
|
)
|
||||||||
|
Taxes for previous years
|
-
|
-
|
(268
|
)
|
-
|
|||||||||||
|
Tax exempt Income
|
(909
|
)
|
(1,299
|
)
|
(1,224
|
)
|
(284
|
)
|
||||||||
|
Other
|
(162
|
)
|
(139
|
)
|
(508
|
)
|
(51
|
)
|
||||||||
|
26,156
|
22,367
|
7,536
|
8,199
|
|||||||||||||
|
The tax rate applicable to the Company for the years 2023 – 2025 is 23%.
|
|
Year ended December 31,
|
||||||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 3
|
2 0 2 5
|
|||||||||||||
|
NIS
|
NIS
|
NIS
|
US Dollars
|
|||||||||||||
|
Basic and diluted earnings per share:
|
||||||||||||||||
|
Earnings used in the calculation of basic and diluted earnings per share
|
90,431
|
70,315
|
31,656
|
28,349
|
||||||||||||
|
Weighted average number of shares used in computing basic earnings per share
|
13,906,412
|
13,874,334
|
13,867,017
|
13,906,412
|
||||||||||||
|
Weighted average number of shares used in computing diluted earnings per share |
13,913,507 | 13,874,334 | 13,867,017 | 13,913,507 | ||||||||||||
F - 25
|
December 31,
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Short-term bank deposits
|
115,623
|
104,090
|
36,245
|
|||||||||
|
Cash in bank
|
8,535
|
18,848
|
2,676
|
|||||||||
|
124,158
|
122,938
|
38,921
|
||||||||||
|
Composition:
|
|
December 31,
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Open accounts
|
166,804
|
153,871
|
52,290
|
|||||||||
|
Checks receivables
|
17,811
|
20,730
|
5,583
|
|||||||||
|
Credit cards
|
836
|
518
|
262
|
|||||||||
|
Less – estimated credit loss
|
(368
|
)
|
(954
|
)
|
(115
|
)
|
||||||
|
Less – provision for return of goods
|
(3,321
|
)
|
(2,834
|
)
|
(1,041
|
)
|
||||||
|
181,762
|
171,331
|
56,979
|
||||||||||
|
The table below shows the open accounts balance as of December 31, 2025, and 2024 segmented by the due date.
|
||||||||||||
|
Open accounts - days past due
|
||||||||||||||||||||||||
|
NIS in thousands
|
||||||||||||||||||||||||
|
As of:
|
Not past due
|
<30
|
31-60
|
61-90
|
90<
|
Total
|
||||||||||||||||||
|
December 31, 2025
|
160,397
|
6,340
|
62
|
5
|
-
|
166,804
|
||||||||||||||||||
|
December 31, 2024
|
150,532
|
3,122
|
117
|
62
|
38
|
153,871
|
||||||||||||||||||
|
Changes in the allowance of credit loss
|
|
December 31,
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Balance at beginning of the year
|
954
|
1,378
|
299
|
|||||||||
|
Changes in allowance for doubtful debts
|
(586
|
)
|
(424
|
)
|
(184
|
)
|
||||||
|
Balance at end of the year
|
368
|
954
|
115
|
|||||||||
F - 26
|
December 31,
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Advances to suppliers
|
654
|
5,991
|
205
|
|||||||||
|
Prepaid expenses
|
399
|
438
|
125
|
|||||||||
|
Others
|
1,191
|
955
|
373
|
|||||||||
|
2,244
|
7,384
|
703
|
||||||||||
|
December 31,
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Finished products
|
81,283
|
83,216
|
25,481
|
|||||||||
|
Inventory in transit
|
13,597
|
16,111
|
4,262
|
|||||||||
|
Less – Provision of slow-moving inventory
|
(806
|
)
|
(1,093
|
)
|
(253
|
)
|
||||||
|
94,074
|
98,234
|
29,490
|
||||||||||
|
The Company records a provision for slow moving inventory in respect of inventory items estimated by management not to be realized due to expiration date. The slow-moving inventory is based on the historic realization rate of the respective item as well as on management's estimate with respect to its future realization rate.
|
F - 27
| New |
Machinery
|
Computers
|
||||||||||||||||||||||||||
|
Land and
|
logistics
|
and
|
Motor
|
and
|
Office
|
|||||||||||||||||||||||
|
Building
|
Center (*)
|
equipment
|
Vehicles
|
equipment
|
Furniture
|
Total
|
||||||||||||||||||||||
|
Consolidated Cost:
|
||||||||||||||||||||||||||||
|
Balance -January 1, 2024
|
59,438
|
26,826
|
13,073
|
11,062
|
9,498
|
2,325
|
122,222
|
|||||||||||||||||||||
|
Changes during 2024:
|
||||||||||||||||||||||||||||
|
Additions
|
341
|
43,332
|
2,562
|
1,028
|
1,213
|
270
|
48,746
|
|||||||||||||||||||||
|
Dispositions
|
-
|
-
|
(999
|
)
|
(1,752
|
)
|
-
|
-
|
(2,751
|
)
|
||||||||||||||||||
|
Balance – December 31, 2024
|
59,779
|
70,158
|
14,636
|
10,338
|
10,711
|
2,595
|
168,217
|
|||||||||||||||||||||
|
Changes during 2025:
|
||||||||||||||||||||||||||||
|
Additions
|
283
|
28,172
|
3,078
|
1,156
|
1,179
|
105
|
33,973
|
|||||||||||||||||||||
|
Dispositions
|
-
|
-
|
-
|
(498
|
)
|
-
|
-
|
(498
|
)
|
|||||||||||||||||||
|
Balance – December 31, 2025
|
60,062
|
98,330
|
17,714
|
10,996
|
11,890
|
2,700
|
201,692
|
|||||||||||||||||||||
|
Accumulated depreciation:
|
||||||||||||||||||||||||||||
|
Balance – January 1, 2024
|
30,859
|
-
|
6,480
|
10,352
|
6,764
|
1,181
|
55,636
|
|||||||||||||||||||||
|
Changes during 2024:
|
||||||||||||||||||||||||||||
|
Additions
|
2,907
|
-
|
496
|
568
|
1,149
|
57
|
5,177
|
|||||||||||||||||||||
|
Dispositions
|
-
|
-
|
(999
|
)
|
(1,465
|
)
|
-
|
-
|
(2,464
|
)
|
||||||||||||||||||
|
Balance – December 31, 2024
|
33,766
|
-
|
5,977
|
9,455
|
7,913
|
1,238
|
58,349
|
|||||||||||||||||||||
|
Changes during 2025:
|
||||||||||||||||||||||||||||
|
Additions
|
2,949
|
-
|
598
|
756
|
1,250
|
64
|
5,617
|
|||||||||||||||||||||
|
Dispositions
|
-
|
-
|
-
|
(498
|
)
|
-
|
-
|
(498
|
)
|
|||||||||||||||||||
|
Balance – December 31, 2025
|
36,715
|
-
|
6,575
|
9,713
|
9,163
|
1,302
|
63,468
|
|||||||||||||||||||||
|
Net book value:
|
||||||||||||||||||||||||||||
|
December 31, 2025
|
23,347
|
98,330
|
11,139
|
1,283
|
2,727
|
1,398
|
138,224
|
|||||||||||||||||||||
|
December 31, 2024
|
26,013
|
70,158
|
8,659
|
883
|
2,798
|
1,357
|
109,868
|
|||||||||||||||||||||
|
Net book value (US Dollars in thousands):
|
||||||||||||||||||||||||||||
|
December 31, 2025
|
7,319
|
30,824
|
3,492
|
402
|
855
|
438
|
43,330
|
|||||||||||||||||||||
|
December 31, 2024
|
8,155
|
21,993
|
2,714
|
276
|
877
|
425
|
34,440
|
|||||||||||||||||||||
|
Property, plant and equipment under construction
|
||||||||||||||||||||||||||||
F - 28
|
All leases are accounted for by recognizing a right-of-use asset and a lease liability except for leases for low value assets and leases with a duration of 12 months or less.
|
|
Lease liabilities are measured at the present value of the contractual payments due to the lessor over the lease term, with the discount rate of borrowing rate on commencement of the lease is used.
|
|
Right to use assets are initially measured at the amount of the lease liability.
|
|
Subsequent to initial measurement lease liabilities increase as a result of interest charged at a constant rate on the balance outstanding and are reduced for lease payments made. Right-to-use assets are amortized on a straight-line basis over the shorter period of the remaining term of the lease or over the remaining economic life of the asset.
|
|
Nature of leasing activities
|
|
The Company enters into agreements for the lease of trucks and private vehicles for periods of 5 and 3 years respectively. The Company's lease payment liability is secured by the lessor’s legal ownership of the assets.
|
|
Right of use assets, net
|
|
December 31,
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Cost:
|
||||||||||||
|
Opening balance
|
7,834
|
5,341
|
2,456
|
|||||||||
|
Dispositions
|
(1,879
|
)
|
(2,322
|
)
|
(589
|
)
|
||||||
|
Additions
|
2,109
|
4,815
|
661
|
|||||||||
|
Closing balance
|
8,064
|
7,834
|
2,528
|
|||||||||
|
Accumulated depreciation:
|
||||||||||||
|
Opening balance
|
3,020
|
3,217
|
947
|
|||||||||
|
Dispositions
|
(1,879
|
)
|
(2,322
|
)
|
(589
|
)
|
||||||
|
Depreciation
|
2,361
|
2,125
|
740
|
|||||||||
|
Closing balance
|
3,502
|
3,020
|
1,098
|
|||||||||
|
Net book value
|
4,562
|
4,814
|
1,430
|
|||||||||
F - 29
|
Note 17 – Leases (continued)
|
|
Leases liabilities
|
|
December 31,
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Opening balance
|
4,700
|
2,207
|
1,474
|
|||||||||
|
Additions
|
2,109
|
4,815
|
661
|
|||||||||
|
Payments
|
(1,879
|
)
|
(2,322
|
)
|
(589
|
)
|
||||||
|
Closing balance
|
4,930
|
4,700
|
1,546
|
|||||||||
|
Amounts recognized in Statement of income
|
|
For the year ended December 31
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Depreciation expense on right-to-use assets
|
2,361
|
2,125
|
740
|
|||||||||
|
Interest expense on lease liabilities
|
296
|
240
|
93
|
|||||||||
|
Cancellation of rental expenses
|
(2,175
|
)
|
(2,563
|
)
|
(681
|
)
|
||||||
|
482
|
(198
|
)
|
152
|
|||||||||
|
The principal subsidiaries of G. Willi-Food International Ltd, all of which have been included in these consolidated financial statements, are as follows:
|
|
Subsidiary
|
Country of
incorporation and principal place of business
|
Proportion of ownership interest
|
||||||||
|
December 31,
|
||||||||||
|
2 0 2 5
|
2 0 2 4
|
|||||||||
|
Euro European Dairies (Goldfrost) Ltd.
|
Israel
|
100
|
%
|
100
|
%
|
|||||
|
W.F.D. (Import, Marketing and Trading) Ltd.
|
Israel
|
100
|
%
|
100
|
%
|
|||||
|
W. Capital Ltd.
|
Israel
|
100
|
%
|
100
|
%
|
|||||
|
December 31,
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Open accounts
|
23,151
|
27,934
|
7,257
|
|||||||||
|
Checks payables
|
140
|
269
|
44
|
|||||||||
|
23,291
|
28,203
|
7,301
|
||||||||||
F - 30
|
Liabilities for employee benefits comprise:
|
|
December 31,
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Employee benefit
|
3,584
|
3,322
|
1,123
|
|||||||||
|
Accrual for annual leave
|
1,277
|
1,210
|
401
|
|||||||||
|
Defined benefit schemes (note 23)
|
1,361
|
1,102
|
427
|
|||||||||
|
6,222
|
5,634
|
1,951
|
||||||||||
|
Estimates and assumptions
|
|
The costs, assets and liabilities of the defined benefit schemes operating by the Company are determined using methods relying on actuarial estimates and assumptions. Details of the key assumptions are set out in note 23. The Company takes advice from independent actuaries relating to the appropriateness of the assumptions. Changes in the assumptions used may have a significant effect on the consolidated statement of comprehensive income and the consolidated statement of financial position.
|
|
December 31,
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Accrued expenses
|
12,195
|
20,900
|
3,822
|
|||||||||
|
Customer advances
|
2,975
|
3,077
|
933
|
|||||||||
|
Other payables
|
2,268
|
1,038
|
711
|
|||||||||
|
17,438
|
25,015
|
5,466
|
||||||||||
|
Composition
|
December 31
|
|||||||
|
2 0 2 5
|
2 0 2 4
|
|||||||
|
Ordinary shares of NIS 0.1 each
|
50,000,000
|
50,000,000
|
||||||
|
Issued and outstanding
|
13,906,412
|
13,874,334
|
||||||
F - 31
|
Defined benefit plans – General
|
|
According to labor laws and the Severance Pay Law in Israel, the Company is required to pay compensation to an employee upon dismissal or retirement (including employees who quit their job under other specific circumstances). The computation of the employee benefit liability is made according to the current employment contract based on the employee's latest salary which, in the opinion of management, establishes the entitlement to receive the compensation and considering the employment term.
|
|
The current legal retirement age is 64 for women, 65 for women who was born after January 1960 and 67 for men. Therefore, according to the plan, an employee who has been employed by the Company for at least one consecutive year (and under circumstances defined by law) and is dismissed after this period, is entitled to severance pay. The rate of compensation stipulated in the Law is the employee's last salary for each year of employment.
|
|
As part of the plan, the Company and its subsidiaries are obligated to deposit amounts, at a rate to be determined by law, in order to secure the accrual of severance pay. As stipulated in the Extension Order (Consolidated Version) of compulsory pension under the laws in Israel (hereinafter: "the Extension Order"). In the reporting year, the Company's rate of provisions for severance pay is 6%, to be deposited in a pension fund / insurance fund.
|
|
The actuary is not employed by the Company and is not dependent thereon. The present value of the defined benefit obligation and the relating costs of current and past services is calculated as the present value (without deducting the plan’s assets) of the future payments expected to settle the liability, in consideration for the current and past services rendered by the employee.
|
|
The plan detailed above exposes the Company to the following risks: "investment risk", i.e., the risk that the program assets will bear a negative yield and thus reduce the plan's assets in a way that does not suffice to cover the obligation. i.e., risk of actuarial assumptions regarding the expected increase in wages will be underestimated Compared with the actual wage increases, thereby exposing the Company to the risk that the obligation will increase accordingly.
|
|
The current value of the Company's post-employment benefits obligation is based on an actuarial estimation. The actuarial estimation was performed by external actuary, member of Israel Association of Actuaries.
|
F - 32
|
Note 23 – Defined benefit scheme (continued)
|
|
The principal assumptions used for the purposes of the actuarial valuations were as follows:
|
|
Valuation at
|
||||||||
|
2 0 2 5
|
2 0 2 4
|
|||||||
|
%
|
%
|
|||||||
|
Discount rate
|
4.61
|
5.44
|
||||||
|
Expected return on the plan assets
|
4.61
|
5.44
|
||||||
|
Rate of increase in compensation
|
5
|
5
|
||||||
|
Expected rate of termination:
|
||||||||
|
0-1 years
|
35
|
35
|
||||||
|
1-2 years
|
35
|
35
|
||||||
|
2-3 years
|
25
|
25
|
||||||
|
3-4 years
|
15
|
15
|
||||||
|
4-5 years
|
15
|
15
|
||||||
|
5 years and more
|
7.5
|
7.5
|
||||||
|
The assumptions regarding future mortality rates are based on mortality tables published and approved by the Ministry of Finance. The mortality rate of an active participant at retirement age (67 for men, 64 for women) is 0.6433% for men and 0.3574% for women.
|
|
The provisions of Standard 19 stipulate that interest used to capitalize assets and liabilities should reflect risk free interest that is interest on highly rated corporate bonds with similar maturity periods and terms. Until November 2014, absent quality data and information about bonds of this type, what was utilized was the interest on long-term index linked government bonds (index linked Galil)/or long-term shackle government bonds (NIS Dawn - “Shachar”). Following a decision by the Securities Authority, according to which there is a deep market for corporate bonds, and according to the publication of Accounting Staff Position number 12-1, as of this report, the capitalization interest is that of high-quality corporate bonds. Use of a quality curve as stated above is published by quoting companies which specialize in this field. The nominal interest rate for the capitalization appropriate for corporate bonds with high rankings as aforesaid, as of December 31, 2025, is 4.61% per year.
|
F - 33
|
Note 23 – Defined benefit scheme (continued)
|
|
Changes in the present value of the defined benefit obligation in the current period were as follows:
|
|
December 31,
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Opening defined benefit obligation
|
6,793
|
5,944
|
2,129
|
|||||||||
|
Current service cost
|
552
|
489
|
173
|
|||||||||
|
Interest cost
|
382
|
327
|
120
|
|||||||||
|
Actuarial losses/(gains) arising from changes in financial assumptions
|
249
|
(7
|
)
|
78
|
||||||||
|
Actuarial losses/(gains) arising from changes in demographic assumptions
|
-
|
(72
|
)
|
-
|
||||||||
|
Actuarial losses arising from experience adjustments
|
301
|
283
|
94
|
|||||||||
|
Benefits paid
|
(25
|
)
|
(171
|
)
|
(8
|
)
|
||||||
|
Closing defined benefit obligation
|
8,252
|
6,793
|
2,586
|
|||||||||
|
Changes in the fair value of the defined benefit assets in the current period were as follows:
|
|
December 31,
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Opening defined benefit assets
|
5,742
|
4,937
|
1,800
|
|||||||||
|
Employer contribution
|
352
|
324
|
110
|
|||||||||
|
Expected return on the plan assets
|
324
|
275
|
101
|
|||||||||
|
Changes in financial assumptions
|
498
|
307
|
156
|
|||||||||
|
Interest losses on severance payment allocated to remuneration benefits
|
(25
|
)
|
(29
|
)
|
(8
|
)
|
||||||
|
Benefits paid
|
-
|
(72
|
)
|
-
|
||||||||
|
Closing defined benefit assets
|
6,891
|
5,742
|
2,159
|
|||||||||
|
Adaption of the current value of defined benefit plan liability and the fair value of the plan's assets to the assets and liabilities recognized in the Balance Sheets:
|
|
December 31,
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Present value of funded liability
|
8,252
|
6,793
|
2,586
|
|||||||||
|
Fair value of unrecognized asset
|
-
|
51
|
-
|
|||||||||
|
Fair value of plan assets - accumulated deposit in executive insurance
|
(6,891
|
)
|
(5,742
|
)
|
(2,159
|
)
|
||||||
|
Net liability deriving from defined benefit obligation
|
1,361
|
1,102
|
427
|
|||||||||
F - 34
|
Note 23 – Defined benefit scheme (continued)
|
|
Sensitivity analyzes principal actuarial assumptions:
|
|
The sensitivity analyzes below have been determined based on reasonably possible changes in actuarial assumptions at the end of the reporting period. Sensitivity analysis does not account for any existing interdependence between assumptions:
|
|
If the discount rate were increased / decreased by 0.5%, the defined benefit obligation would have decreased / increased by NIS 150 thousand (USD 47 thousand).
|
|
If the rate hikes expected salaries would have increased / decreased by 0.5%, the defined benefit obligation would have increased / decreased by NIS 200 thousand (USD 63 thousand).
|
|
If the resignation rate had increased / decreased by 5%, the defined benefit obligation would have increased / decreased by NIS 82 thousand (USD 26 thousand).
|
|
Short-term employee benefits:
|
|
Paid Annual Leave
|
|
In accordance with the Annual Leave Law, 1951, Company employees are entitled to several leave days per each working year. According to the above law (and addendums determined in personal contracts between the Company and several employees), the leave days due to an employee during the year is established based on the number of years of employment of that employee.
|
|
The employee may use leave days based on the employee's needs and with the Company's consent and to accumulate the remaining unused leave days based on the employee's personal employment contract. An employee who ceases employment before using the balance of leave days is entitled to payment for the above balance of leave days.
|
|
The balance of the Company's vacation provision is in accordance with the leave entitlement of each individual employee, according to his individual agreement with the company to which the employee belongs and in accordance with the employee's salary. The balance of the Company's vacation provision for December 31, 2025, as NIS 1,079 thousand (NIS 1,062 thousand, as of December 31, 2024).
|
|
Paid Sick Leave
|
|
In accordance with the Sick Pay Law, 1976, the Company's employees are entitled to 18 sick days per year (1.5 sick days per month). Sick days may be used only with medical confirmation of an employee's illness. Employees who cease employment before using the sick days due to the employee is not entitled to payment for the above balance of sick days and, therefore, such provision is not recorded in the Company's books.
|
F - 35
|
On July 2022, the Company granted to its employees 164,000 non-marketable options exercised to up to 164,000 ordinary shares of the Company. However, the actual number of shares allocated may be lower than stated, as the offerees will be entitled to exercise the option warrants via "cashless" method, meaning the allocation of shares in an amount reflecting the monetary benefit inherent in the offered option warrants. Each option will allow, upon exercise, to purchase one NIS 1 ordinary share at an exercise price of NIS 55.3, adjusted to dividend and subject to adjustments that will be required if rights or bonus shares are issued.
|
|
The fair value of all the options at the time of grant was approximately NIS 3 million. The fair value of the options was measured using the Black & Scholes model, using the following average indices: standard deviation in the range of approximately 39% to 44%, and the life of the option: 3 years for the first tranche, 4 years for the second tranche and 5 years for the 3rd tranche The standard deviation was calculated based on the historical daily standard deviation of the company's stock traded on the Tel Aviv Stock Exchange. As of December 31, 2025, all options have expired and/or been exercised.
|
|
On May 2025, the Company granted to three senior managers, 75,000 non-marketable options exercised to up to 75,000 ordinary shares of the Company. However, the actual number of shares allocated may be lower than stated, as the offerees will be entitled to exercise the option warrants via "cashless" method, meaning the allocation of shares in an amount reflecting the monetary benefit inherent in the offered option warrants. Each option will allow, upon exercise, to purchase one NIS 1 ordinary share at an exercise price of NIS 53.51, adjusted to dividend and subject to adjustments that will be required if rights or bonus shares are issued.
|
|
The fair value of all the options at the time of grant was approximately NIS 1.2 million. The fair value of the options was measured using the Black & Scholes model, using the following average indices: standard deviation in the range of approximately 39% to 44%, and the life of the option: 3 years for the first tranche, 4 years for the second tranche and 5 years for the 3rd tranche The standard deviation was calculated based on the historical daily standard deviation of the company's stock traded on the Tel Aviv Stock Exchange.
|
F - 36
|
Note 24 – Share based payment (continued)
|
|
On August 2025, the Company granted to each Mr. Joseph Williger CEO and Mr. Zwi Williger Chairman of the board 100,000 (200,000 total) non-marketable options exercised to up to 100,000 (200,000 total) ordinary shares of the Company, with the same terms granted to the senior managers as stated above.
|
|
The fair value of all the options at the time of grant was approximately NIS 3.2 million. The fair value of the options was measured using the Black & Scholes model, using the following average indices: standard deviation in the range of approximately 39% to 44%, and the life of the option: 3 years for the first tranche, 4 years for the second tranche and 5 years for the 3rd tranche The standard deviation was calculated based on the historical daily standard deviation of the company's stock traded on the Tel Aviv Stock Exchange.
|
|
Stock options for senior management
|
Stock options for owners
|
Total options
|
|||||||
|
Outstanding period
|
May 2025
|
May 2025
|
May 2025
|
||||||
|
Granted during the year
|
75,000
|
200,000
|
275,000
|
||||||
|
Estimated lifespan
|
2-5 years
|
2-5 years
|
2-5 years
|
|
Stock options for senior management
|
Stock options for other employees
|
Total options
|
|||||||
|
Outstanding period
|
July 2022
|
July 2022
|
July 2022
|
||||||
|
Granted during the year
|
75,000
|
89,000
|
164,000
|
||||||
|
Estimated lifespan
|
2-5 years
|
2-5 years
|
2-5 years
|
F - 37
|
Note 24 –Share based payment (continued) |
24.2 - Details regarding the stock option plans
|
2025
|
2024
|
2025
|
||||||||||||||||||
|
Number
|
Weighted average Exercise price (NIS)
|
Number
|
Weighted average Exercise price (NIS)
|
Weighted average Exercise price (US Dollars)
|
||||||||||||||||
|
Opening balance
|
103,676
|
49.16
|
141,500
|
49.88
|
16.77
|
|||||||||||||||
|
Expired during the year
|
(2,792
|
)
|
49.16
|
-
|
-
|
16.77
|
||||||||||||||
|
Exercised during the year
|
(100,884
|
)
|
49.16
|
(37,824
|
)
|
49.16
|
16.77
|
|||||||||||||
|
Granted during the year
|
275,000
|
53.51
|
-
|
-
|
16.77
|
|||||||||||||||
|
Closing balance
|
275,000
|
53.51
|
103,676
|
49.16
|
16.77
|
|||||||||||||||
The exercise price of the options outstanding as of December 31, 2025, is NIS 53.51 per option.
|
24.3 - Effect of share-based payment transactions on profit or loss for the period
|
|
Year ended December 31,
|
||||||||||||
|
2 0 2 5
|
2 0 2 4
|
2 0 2 5
|
||||||||||
|
NIS
|
NIS
|
US Dollars
|
||||||||||
|
Expense arising from plans to grant shares and stock options
|
1,639
|
473
|
514
|
|||||||||
F - 38
|
- The Company has an obligation to pay incentives to several customers that are not subject to the Food Law, 5744-2014, which came into effect on January 15, 2015. Some of those incentives are payable as a rate of total annual sales to those customers, and some of those incentives are payable as a rate of acquisitions in excess of an agreed upon annual volume of activities. The incentives are calculated specifically for each customer. The incentives are calculated specifically for each customer as a reduction of the revenue.
|
|
- On February 27, 2025, a General Meeting of the Shareholders of the Company approved a new management services agreements pursuant to which Messrs. Yosef Williger and Zwi Williger are to serve as CEO of the company and chairmen of the Board of Directors, respectively.
The Company's shareholders also approved new terms of service for each of Mr. Zwi Williger and Mr. Joseph Williger, commencing as of January 1, 2025 as follows.
(a) Monthly service fees of NIS 108,300 (USD 33.9 thousand) (excluding VAT).
(b) Profit Related Bonus - an annual bonus determined according to measurable quantitative criteria:
- Payment of the Measurable Bonus will be subject to achieving an average of the minimum profit before taxes of the Company before bonuses during the last three (3) years (i.e., the year in which the bonus is granted and the previous two (2) years) (the “Bonuses” and "Average Operating Profit Before Bonuses", respectively) of at least NIS 40 million (USD 12.5 million) (the “Minimum Average Operating Profit before Bonuses”).
- Subject to the Company's achieving or exceeding the Minimum Average Operating Profit before Bonuses, the Chairman/ CEO shall be entitled to receive a bonus in the following manners: (i) a Bonus of 2.5% of the Average Profit before taxes Before Bonuses for the amount exceeding above NIS 10 million (USD 3.1 million) and up to and including NIS 15 million (USD 4.7 million); (ii) a Bonus of 3% of the Average Profit before taxes Before Bonuses for the amount exceeding above NIS 15 million and up to and including NIS 25 million (USD 7.8 million); (iii) a Bonus of 4.15% of Average Profit before taxes Before Bonuses for the amount exceeding NIS 25 million and up to and including NIS 40 million (USD 12.5 million); (iv) a Bonus of 5% of the Average Profit before taxes Before Bonuses for the amount exceeding above NIS 40 million and up to and including NIS 55 million (USD 17.2 million); and (v) a Bonus of 5.5% of the Average Profit before taxes Before Bonuses for any amount exceeding above NIS 55 million.
- The maximum annual Bonus to be paid to the Chairman / CEO will not exceed an amount of NIS 2.4 million (USD 752.4 thousand).
(c) The Company will provide the Chairman/ CEO with use of a vehicle, the value of which shall not exceed NIS 400,000 (USD 125.4 thousand). The Company shall allow the Chairman/ CEO to use a vehicle exceeding the value of NIS 400,000, upon the Chairman's/ CEO 's request provided that the Chairman/ CEO will reimburse the Company with any amount exceeding NIS 400,000. The Company will cover all the operating expenses of the Company car (excluding fines), including grossing up the related tax. The Company estimates the annual amount of the Company car benefits in the total amount of NIS 300,000.
|
F - 39
|
Note 25 – Contingent liabilities and commitments (continued)
|
|
(d) Benefits in general, including the social benefits of the Chairman/ CEO and income tax payments, national insurance payments and other payments due to employees in respect of their employment, are to be paid for at the sole expense of the Chairman and CEO 's Management Company. The Chairman and CEO 's Management Company has undertaken to indemnify the Company with respect to any claims against the Company with respect to employer/employee relations.
(e) The Chairman/ CEO will be included in the D&O insurance policy available to the Company and its subsidiaries under the same terms as other officers of the Company, and he will be entitled to an exemption and indemnification letter, which is identical to the form of exemption and indemnification that was approved by the General Meeting of Shareholders on July 20, 2005 for all directors and officers of the Company. It is hereby clarified, that the exemption does will not be valid regarding apply to any decision or transaction of the Company, in which a controlling shareholder or other officer of the Company, (including a different officer than the officer that has been granted the exemption letter) has a personal interest.
|
|
- On April 1, 1997, the parent Company, Willi-Food Investments Ltd., and the Company entered into an agreement for the provision of management, administration, bookkeeping, secretarial and controllership services. Pursuant to the said agreement, the parent company shall pay the Company a monthly amount for the said services and for external services that are provided at the same time to the parent Company and to the subsidiary by the same third party, such as legal services, auditing services, etc., but excluding unique and specific services that are provided to the parent Company or to the company, a monthly payment of NIS 10,000 plus VAT. The agreement was renewed on March 14, 2023.
|
|
- On November 4, 2018, G. Willi-Food Ltd. filed a lawsuit in the amount of NIS 4,183,208 against the Company’s former controlling shareholder, Gregory Gurtovoy (“Mr. Gurtovoy”), and against five former directors and senior officers of the Company – Israel Joseph Schneerson, Pavel Buber, Iram Ephraim Graiver, Ilan Menachem Admon and Zalman Vigler (together, the “Defendants”). According to the Company, the Defendants conspired to cause the use of millions of NIS of the Company funds as collaterals to loans extended to foreign private companies related to the Company’s controlling shareholders on dates which are relevant to the lawsuit without obtaining the required approvals from the Company’s directors and without issuing the required report to Company’s shareholders.
|
F - 40
|
Note 25 – Contingent liabilities and commitments (continued)
|
|
As of the date of this report, the proceedings in this case have been concluded with respect to all of the Defendants except for Iram Graiver.
|
|
- On July 23, 2017, Mr. Iram Graiver, the Company's CEO and former executive ("Mr. Graiver"), filed a lawsuit with the Regional Labor Court in Tel Aviv-Jaffa ("the Court") for social benefits and various compensations totaling NIS 2,377,305. The Company submitted a statement of defense on November 26, 2017. On July 27, 2017, The Company filed a lawsuit against Mr. Graiver for the return of funds allegedly taken unlawfully, totaling NIS 1,694,325. According to the Company, Mr. Graiver acted in breach of his fiduciary duty and contrary to the mandatory provisions of the Companies Law, 1999, which require approval from the general shareholders' meeting (which was not obtained) for payments he took from the Company.
|
F - 41
|
Note 25 – Contingent liabilities and commitments (continued)
|
|
- On November 2, 2017, the Court decided to consolidate the two proceedings. On November 26, 2017, defense statements were submitted by Mr. Graiver and the Company. After several hearings, a judgment was issued on November 27, 2022, ordering the company to pay Mr. Graiver approximately NIS 255,000. Subsequently, both the company and Mr. Graiver filed appeal requests to the National Labor Court.
On September 24, 2024, a judgment was issued rejecting the company's appeal and partially accepting Mr. Graiver's appeal. It was determined that, in addition to funds already deposited with the Court, the company must pay Mr. Graiver an additional NIS 411,297 plus interest and linkage from March 2017. On October 20, 2024, a petition was filed with the High Court of Justice. The hearing on the petition was held on February 16, 2026. In a judgment dated February 17, 2026, the court ruled that Mr. Graiver is required to reimburse the Company 20% of the reasonable salary amount, as determined in the judgment of the National Labor Court.
|
|
- On June 24, 2020, a lawsuit and request for approval as a representative was submitted to the Central District Court against the company, Euro Dairy Europe Ltd. and another respondent. According to the applicant, the company marketed a number of products with misleading labeling and contrary to the provisions of the law and the relevant standards. On April 22, 2025, the court approved the certification of the class action lawsuit on the grounds of misrepresentation. In November 2025, a settlement agreement was submitted to the court for approval, pursuant to which G. Willi‑Food will donate products with a total value of NIS 230,000 to various nonprofit organizations.
|
|
- A lawsuit and a motion to approve it as class action was filed on August 2, 2021, against the Company and another 5 respondents to the District Court. The applicant claimed that the Company marketed several products with misleading captions and contrary to the provisions of the law and the relevant regulations. The applicant claims that he and the members of the group suffered financial damages in amount of NIS 100 million and Non-financial damages in amount of NIS 378 million. On December 25, 2025, a withdrawal settlement was approved, pursuant to which the Company undertook to present tests of the products that are the subject of the claim, confirming that they are consistent with the manufacturer’s declarations. The claim was dismissed.
|
F - 42
|
Note 25 – Contingent liabilities and commitments (continued)
|
|
- A lawsuit and a motion to approve it as class action was filed on November 8, 2021, against the Company to the District Court. The applicant claimed that the Company marketed a product with misleading captions and contrary to the provisions of the law and the relevant regulations. The applicant claims that he and the members of the group suffered damages in amount of NIS 57 million. A response was submitted on February 9, 2022. On November 14, 2022, a pre- trial hearing was held, at the end of which it was decided that the parties must reach agreements by December 15, 2022. On January 24, 2023, an agreed notification was submitted according to which the parties were unable to reach an agreement. On September 14, 2023 another pre-trial hearing was held. Summaries on behalf of the applicant were submitted on December 27, 2023. Response summaries have been submitted, awaiting a decision on the approval request. On December 3, 2024 the District Court approved the lawsuit as class action. The District Court ruled in its decision that at the certification request stage, there is no need to determine the extent of damages, and that this issue should be clarified in the second phase of managing the claim. The District Court determined that there are grounds to examine the petitioner's claim that he and the group members suffered damages in the amount of the difference between the price paid and the price they would have paid for purchasing another comparable product. According to the petitioner, the product's price was higher than that of another comparable product, while the Company argues that the product subject to the claim was sold at lower prices than competing products and therefore no damage was caused. The District Court also ruled that there are grounds to examine the question of non-monetary damages caused by the inability to compare between the product subject to the claim and competing products. The Company maintains its argument that this was a good faith mistake and that no damage was caused to the consumer, and in the proceedings, it will prove that the product was imported in relatively small quantities during a limited period only. The case was scheduled for the submission of affidavits of primary testimony, followed by a pre‑trial hearing, on July 15, 2026.
|
|
- On February 20, 2023, the Euro European Dairies (the Company) received, from the Ashdod Customs House, a notice of a charge for a deficit of NIS 1.75 million, which includes interest and fine. In the letter of demand, it is claimed that the company imported soft cheeses in a saltwater solution and paid duty only for the weight of the cheese without the weight of the saltwater solution. According to the customs house, customs must also be paid for the saltwater solution. After the customs house rejected the appeal that the company filed on the debit notices, The company paid the debt in the debit notices and submitted a lawsuit to the Magistrate's Court in Petah Tikva to cancel the notices and to recover the amounts paid by it plus interest and linkage.
|
F - 43
|
Note 25 – Contingent liabilities and commitments (continued)
|
|
The first pretrial hearing was scheduled for May 15, 2024. During the hearing, the court pointed out difficulties in the positions of each of the parties and proposed referring the case to mediation. Euro Dairies Europe agreed to the proposal, however, the Customs Authority rejected it. On March 24, 2025, an additional hearing was held, during which the court approved the request for expert testimony and again recommended referring the matter to mediation. On April 8, the Customs Authority announced that it refuses to engage in mediation. An evidentiary hearing in the case was held on November 23, 2025. At the conclusion of the hearing, the defendant announced that it does not accept the court’s recommendation to refer the matter to mediation. Accordingly, the court set a hearing for an attempt to resolve the dispute on May 10, 2026. At this preliminary stage, it is difficult to assess the prospects of the application and the claim.
|
|
- On February 11, 2026, a claim and a motion for its approval as a class action were filed with the Central District Court against G. Willi‑Food. According to the allegations set forth in the motion for approval, G. Willi‑Food marketed a product bearing misleading labeling, contrary to the provisions of the law and the relevant standards. As alleged in the motion for approval, the amount of the individual claim is NIS 2,580, while the total amount of the claim was estimated, at this stage, at more than NIS 2.5 million, in respect of the aggregate damage allegedly caused to the members of the represented class. At this preliminary stage, it is not possible to assess the likelihood of the motion being approved or the extent of the exposure arising therefrom.
|
|
Note 26 – Events during and after the reporting period
|
|
- On March 21, 2024, the Company's Board of Directors announced a dividend distribution in the amount of NIS 10 million (a total of NIS 0.72 per share).
|
|
- On March 11, 2025, the Company's Board of Directors announced a dividend distribution in the amount of NIS 30 million (a total of NIS 2.16 per share).
|
|
- On August 12, 2025, the Company's Board of Directors announced a dividend distribution in the amount of NIS 20 million (a total of NIS 1.44 per share).
|
F - 44
|
- On February 14, 2024, the Company received a notification letter from the Competition Authority, according to which the authority is considering filing an indictment against the Company, subject to a hearing, on the grounds of the suspicions listed in the "Letter of Suspicions". In addition, A similar message was further delivered to the chairman of the board of directors of the Company, Mr. Zwi Williger, one of the controlling owners of the Company. On April 17, 2024, a hearing was held regarding the aforementioned matter, in which the company and Mr. Williger presented their arguments before the Competition Authority.
|
|
- On July 17, 2024, the Company reached an agreement with the Competition Authority regarding the payment of financial sanctions totaling approximately 11.6 million NIS for alleged violations of the Food Industry Competition Promotion Law of 2014, without admission of violation. The aforementioned arrangement was approved by the Company's board of directors. The Company included the expenses related to this agreement in its financial statements under other expenses.
|
|
- On July 21, 2024, following an agreement with the Competition Authority, a request for document disclosure was filed pursuant to Section 198a of the Companies Law, 5759-1999, in the Tel Aviv-Jaffa District Court against the Company to examine the possibility of filing a derivative claim for alleged violations of the Food Industry Competition Promotion Law, 5774-2014. As part of the request, the court was asked to order the Company to provide various documents related to these events to the petitioner. On December 24, 2024, the Company filed a response to the request. On February 18, 2025, the parties filed a mutual withdrawal request. The court approved the withdrawal request on the same day.
|
|
- On November 19, 2025, the Company received a notice from the Competition Authority regarding the closure of the investigation file against the Company. In addition, a notice in identical wording regarding the closure of the investigation file against him was also delivered to Mr. Zvi Williger, one of the Company’s controlling shareholders, who serves as Chairman of the Board of Directors of the Company.
|
|
- On July 2022, the Company granted its employees 164,000 options (not listed for trading) free of charge. Each option is exercisable into one ordinary share of the Company at an exercise price of NIS 55.3 (not linked), subject to customary adjustments, inter alia, in respect of dividend distributions, bonus share distributions, and rights offerings. The options are exercisable in three annual tranches, with the first tranche becoming exercisable 12 months from the grant date. The exercise period for each tranche shall be up to two (2) years from the date such tranche vests.
|
F - 45
|
Note 26 – Events during and after the reporting period (continued)
|
|
- The fair value of the options on the grant date was approximately NIS 3 million. The fair value of the options was measured using the Black & Scholes model, based on the following average assumptions: volatility in the range of approximately 39% to 44%, and option life of 3 years for the first tranche, 4 years for the second tranche, and 5 years for the third tranche. The volatility was calculated based on the historical daily volatility of the Company’s share price as traded on the Tel Aviv Stock Exchange.
- On May 18, 2025, the Company granted three senior executives an aggregate of 75,000 options (not listed for trading) free of charge. Each option is exercisable into one ordinary share of G. Willi‑Food at an exercise price of NIS 54.95 (not linked), subject to customary adjustments, inter alia, in respect of dividend distributions, bonus share distributions, and rights offerings. The options are exercisable in three annual tranches, with the first tranche becoming exercisable 12 months from the grant date. The exercise period for each tranche shall be up to two (2) years from the date such tranche vests.The fair value of these options on the grant date was approximately NIS 1.2 million. The fair value of the options was measured using the Black & Scholes model, based on the following average assumptions: volatility in the range of approximately 39% to 44%, and option life of 3 years for the first tranche, 4 years for the second tranche, and 5 years for the third tranche. The volatility was calculated based on the historical daily volatility of the Company’s share price as traded on the Tel Aviv Stock Exchange.
On August 7, 2025, the general meeting of the Company approved the grant of 100,000 options free of charge to each of Mr. Yosef Williger, Director and CEO of the subsidiary, and Mr. Zwi Williger, Chairman of the Board of Directors of the Company (200,000 options in total). The terms of these options are identical to the terms of the options granted to the senior executives as described above. The fair value of the options on the grant date was approximately NIS 3.2 million.
The actual number of shares to be issued upon exercise of the options may differ from the foregoing, since the offerees may elect to exercise all or part of their options on a cashless basis, in which case not all of the shares underlying the options will be issued, but rather a number of shares reflecting the monetary benefit inherent in the options exercised.
In October 2023, Hamas terrorists infiltrated Israel’s southern border from the Gaza Strip and conducted a series of attacks on civilian and military targets. Following the attack, Israel’s security cabinet declared war against Hamas, and later against Hezbollah in Lebanon. Hostilities subsequently escalated between Israel and a number of its other neighbors, including conflicts with Hezbollah along Israel’s northern border with Lebanon, with Iran (including a war during June 2025) and with the Houthi movement in Yemen, which both launched drone and missile attacks on military and civilian targets within Israel. In addition, the Houthi movement disrupted international commerce by launching a number of attacks on commercial vessels traversing the Gulf of Aden and the Red Sea. While a ceasefire between Israel and Lebanon (with respect to Hezbollah) was announced in November 2024, a ceasefire between Israel and Iran was announced in June 2025 and the latest ceasefire between Israel and Hamas was announced in October 2025, in February 2026, hostilities between Israel and Iran escalated again. In late February 2026, the United States, together with Israel, launched a major joint military campaign of air and missile strikes against targets in Iran, which triggered a broad Iranian response and contributed to significant regional instability, including, in early March 2026, resumed conflicts with Hezbollah. The security situation in the region remains highly fluid, and we are unable to predict if, when, or on what terms, this escalation will be resolved.
The military operation against Iran has immediate implications for the Israeli economy, including, inter alia, the declaration of a state of emergency, the issuance of emergency orders and restrictions on economic activity, the shutdown of educational institutions and workplaces, a reduction in activity across various sectors, and the mobilization of reserve forces on a broad scale. These measures may give rise to operational disruptions, delays in timelines, and increased costs and reduced availability of products imported by us, as well as elevated personnel costs.
As a result of repeated attacks by Houthi forces on vessels operating in the Red Sea, shipping times from the Far East have been extended by three to four weeks. Approximately 35% of our imported products originate in the Far East. We estimate that a material increase in maritime shipping costs could adversely affect our results of operations. Furthermore, as a result of Iran's blockade of the Strait of Hormuz, energy prices – and oil prices in particular – have risen. These developments may adversely affect shipping costs and give rise to potential supply chain delays, which could impact, inter alia, the availability and cost of the Company's imported products. Further, as an Israeli company, there is heightened risk of cyberattacks on our and our supply chain’s IT networks by our adversaries in general, and more so as a result of a war.
Several countries, principally in the Middle East, restrict doing business with Israel and Israeli companies, and additional countries may impose restrictions on doing business with Israel and Israeli companies if hostilities in the region continue. Moreover, the perception of Israel and Israeli companies by the global community (as represented, for example, by claims filed with the International Court of Justice (the “ICJ”)) may cause an increase in sanctions and other adverse measures against Israel, Israeli companies and their products and services. Additionally, there have been increased efforts by countries, activists and organizations to cause companies and consumers to restrict business with Israel and with Israeli companies, which may impact our ability to do business. Such efforts, particularly if they become widespread, as well as current and future rulings and orders of international tribunals including the ICJ against Israel, could materially and adversely impact our business operations.
Any hostilities involving Israel or the interruption or curtailment of trade between Israel and its present trading partners, or significant downturns in the economic or financial condition of Israel, could adversely affect our operations and product development, cause our revenues to decrease and adversely affect the share price of publicly traded companies having operations in Israel, such as us. Our commercial insurance does not cover losses that may occur as a result of an event associated with the security situation in the Middle East. Although the Israeli government is currently committed to covering the reinstatement value of direct damages that are caused by terrorist attacks or acts of war, there can be no assurance that this government coverage will be maintained, or if maintained, will be sufficient to compensate us fully for damages incurred. Any losses or damages incurred by us could have a material adverse effect on our business, financial condition and results of operations. |
F - 46
|
Revenue
|
|
Performance obligations and timing of revenue recognition:
|
|
The majority of the Company's revenue is derived from selling goods in the Israeli market with revenue recognized at a point in time when control of the goods has transferred to the customer. This is generally when the goods are delivered to the customer. However, for export sales, control might also be transferred when delivered either to the port of departure or port of arrival, depending on the specific terms of the contract with a customer. There is limited judgement needed in identifying the point control passes: once physical delivery of the products to the agreed location has occurred, the group no longer has physical possession, usually will have a present right to payment (as a single payment on delivery) and retains none of the significant risks and rewards of the goods in question.
|
|
Determining the transaction price:
|
|
Most of the Company's revenue is derived from fixed price contracts, therefore the amount of revenue to be earned from each contract is determined by reference to those fixed prices agreed with the customers. Customers have the right to return products they purchase from the company in some transactions. Whenever a transaction includes the possibility of a return, the company recognizes revenue according to the consideration it expects to receive for products not expected to be returned, and on the other hand, it recognizes the obligation to refund.
|
|
Historical experience enables the Company to estimate reliably the value of good that will be returned and restrict the amount of revenue that is recognized such that it is highly probable that there will not be a reversal of previously recognized revenue when goods are return.
|
|
Allocating amounts to performance obligations:
|
|
For most contracts, there is a fixed unit price for each product sold, with reductions given for bulk orders placed at a specific time. Therefore, there is no judgement involved in allocating the contract price to each unit ordered in such contracts (it is the total contract price divided by the number of units ordered). Where a customer orders more than one product line, the Company is able to determine the split of the total contract price between each product line by reference to each product’s standalone selling prices (all product lines are capable of being, and are, sold separately).
|
F - 47
|
Note 27 – Accounting policies (continued)
|
|
Inventories
|
|
Inventories are initially recognized at cost, and subsequently at the lower of cost and net realizable value. Cost comprises all costs of purchase, costs of conversion and other costs incurred in bringing the inventories to their present location and condition.
|
|
Weighted average cost is used to determine the cost of the inventories.
|
|
The Company continuously reviews its inventory levels to identify slow-moving merchandise and markdowns necessary to clear slow-moving merchandise, which reduces the cost of inventories to its estimated net realizable value. Consideration is given to a number of quantitative and qualitative factors, including current pricing levels and the anticipated need for subsequent markdowns, aging of inventories, historical sales trends, and the impact of market trends and economic conditions. Estimates of markdown requirements may differ from actual results due to changes in quantity, quality and mix of products in inventory, as well as changes in consumer preferences, market and economic conditions. The Company’s historical estimates of these costs and its markdown provisions have not differed materially from actual results.
|
|
Basis of consolidation
|
|
Where the Company has control over an investee, it is classified as a subsidiary. The Company controls an investee if all three of the following elements are present: power over the investee, exposure to variable returns from the investee, and the ability of the investor to use its power to affect those variable returns. Control is reassessed whenever facts and circumstances indicate that there may be a change in any of these elements of control.
|
|
The consolidated financial statements present the results of the Company and its subsidiaries as if they formed a single entity. Intercompany transactions and balances between group companies are therefore eliminated in full.
|
|
Cash and Cash equivalents
|
|
Cash and cash equivalents include demand deposits and term deposits in banks that are not restricted as to usage, with an original period to maturity of not more than three months.
|
|
Deposits that are restricted as to usage are classified as pledged deposits.
|
|
Deposits with an original period to maturity exceeding three months, which as of the statement of financial position do not exceed one year, are classified as short-term investments
|
F - 48
|
Note 27 – Accounting policies (continued)
|
|
Leases
|
|
The majority of the Company's accounting policies for leases are set out in note 19.
|
|
Identifying leases
|
|
The Company accounts for a contract as a lease when it conveys the right to use an asset for a period of time in exchange for consideration. Leases are those contracts that satisfy the following criteria:
|
|
- There is an identified asset;
|
|
- The Company obtains substantially all the economic benefits from use of the asset; and
|
|
- The company has the right to direct use of the asset
|
|
The Company considers whether the lessor has substantive substitution rights. If the supplier does have those rights, the contract is not identified as giving rise to a lease.
|
|
In determining whether the Company obtains substantially all the economic benefits from use of the asset, the Company considers only the economic benefits that arise from the use of the asset, not those incidental to legal ownership or other potential benefits.
|
|
In determining whether the Company has the right to direct use of the asset, the Company considers whether it directs how and for what purpose the asset is used throughout the period of use. If there are no significant decisions to be made because they are pre-determined due to the nature of the asset, the Company considers whether it was involved in the design of the asset in a way that predetermines how and for what purpose the asset will be used throughout the period of use. If the contract or portion of a contract does not satisfy these criteria, the Company applies other applicable IFRSs rather than IFRS 16.
|
|
Property, plant and equipment
|
|
Property, plant and equipment are tangible items, which are held for use in the manufacture or supply of goods or services, or leased to others, which are predicted to be used for more than one period. The Company presents its property, plant and equipment items according to the cost model.
|
|
Under the cost method - a property, plant and equipment are presented at the balance sheet at cost (net of any investment grants), less any accumulated depreciation and any accumulated impairment losses. The cost includes the cost of the assets acquisition as well as costs that can be directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.
|
|
|
|
Depreciation is calculated using the straight-line method at rates considered adequate to depreciate the assets over their estimated useful lives. Amortization of leasehold improvements is computed over the shorter of the term of the lease, including any extension period, where the Company intends to exercise such option, or their useful life.
|
F - 49
|
Note 27 – Accounting policies (continued)
|
|
Useful life (Years)
|
%
|
||||||
|
Building
|
50
|
2
|
|||||
|
Construction
|
25
|
4
|
|||||
|
Motor vehicles
|
5
|
15-20
|
(Mainly 20%)
|
||||
|
Office furniture and equipment
|
6
|
6-15
|
(Mainly 15%)
|
||||
|
Computers
|
3
|
20-33
|
(Mainly 33%)
|
||||
|
Machinery and equipment
|
10
|
10
|
|
The gain or loss arising on the disposal or retirement of an item of property, plant and equipment is determined as the difference between the sales proceeds and the carrying amount of the asset and is recognized in the Income statement.
|
|
Provisions
|
|
|
Provisions are recognized when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that the Company will be required to settle the obligation, and a reliable estimate can be made of the amount of the obligation.
|
|
|
The amount recognized as a provision is the best estimate of the consideration required to settle the present obligation at the balance sheet date, taking into account the risks and uncertainties surrounding the obligation.
|
|
|
Where a provision is measured using the cash flows estimated to settle the present obligation, it carrying amount is the present value of those cash flows.
|
|
|
When some or all of the economic benefits to settle a provision are expected to be recovered from a third party, the receivable is recognized as an asset if it is virtually certain that reimbursement will be received and the amount of the receivable can be measured reliably.
|
|
Share-based payments
|
|
|
Where equity settled share options are awarded to employees, the fair value of the options at the date of grant is charged to the consolidated statement of comprehensive income over the vesting period. Non-market vesting conditions are taken into account by adjusting the number of equity instruments expected to vest at each reporting date so that, ultimately, the cumulative amount recognized over the vesting period is based on the number of options that eventually vest. Non-vesting conditions and market vesting conditions are factored into the fair value of the options granted. As long as all other vesting conditions are satisfied, a charge is made irrespective of whether the market vesting conditions are satisfied. The cumulative expense is not adjusted for failure to achieve a market vesting condition or where a non-vesting condition is not satisfied.
|
F - 50
|
Note 27 – Accounting policies (continued)
|
|
Deferred taxes
|
|
Deferred tax assets and liabilities are recognized where the carrying amount of an asset or liability in the consolidated statement of financial position differs from its tax base.
|
|
Recognition of deferred tax assets is restricted to those instances where it is probable that taxable profit will be available against which the difference can be utilized.
|
|
The amount of the asset or liability is determined using tax rates that have been enacted or substantively enacted by the reporting date and are expected to apply when the deferred tax liabilities/(assets) are settled/(recovered).
|
|
Defined benefit schemes
|
|
Defined benefit scheme surpluses and deficits are measured at:
|
|
- The fair value of plan assets at the reporting date; less
|
|
- Plan liabilities calculated using the projected unit credit method discounted to its present value using yields available on high quality corporate bonds that have maturity dates approximating to the terms of the liabilities and are denominated in the same currency as the post-employment benefit obligations; less
|
|
- The effect of minimum funding requirements agreed with scheme trustees.
|
|
Remeasurements of the net defined obligation are recognized directly within equity. The remeasurements include:
|
|
- Actuarial gains and losses.
|
|
- Return on plan assets (interest exclusive).
|
|
- Any asset ceiling effects.
|
|
Service costs are recognized in profit or loss, and include current and past service costs as well as gains and losses on curtailments.
|
|
Net interest expense (income) is recognized in profit or loss, and is calculated by applying the discount rate used to measure the defined benefit obligation (asset) at the beginning of the annual period to the balance of the net defined benefit obligation (asset), considering the effects of contributions and benefit payments during the period. Gains or losses arising from changes to scheme benefits or scheme curtailment are recognized immediately in profit or loss.
|
|
Settlements of defined benefit schemes are recognized in the period in which the settlement occurs.
|
F - 51
|
Note 27 – Accounting policies (continued)
|
|
Share capital
|
|
Financial instruments issued by the Company are classified as equity only to the extent that they do not meet the definition of a financial liability or financial asset.
|
|
The Company's ordinary shares are classified as equity instruments.
|
|
there are separately identifiable cash flows; its cash generating units ('CGUs'). Goodwill is allocated on initial recognition to each of the Company's CGUs that are expected to benefit from a business combination that gives rise to the goodwill.
|
|
Impairment charges are included in profit or loss, except to the extent they reverse gains previously recognized in other comprehensive income. An impairment loss recognized for goodwill is not reversed.
|
|
Financial assets and liabilities
|
|
The Company classifies its financial assets and liabilities into one of the categories discussed below, the Company's accounting policy for each category is as follows:
|
|
- Fair value through profit or loss
|
|
Financial assets and liabilities at fair value through profit or loss are measured at fair value at the end of each reporting period They are carried in the statement of financial position at fair value with changes in fair value recognized in the consolidated statement of income in the finance income or expense line.
|
|
Amortized cost
|
|
The Company's financial assets (liabilities) measured at amortized cost comprise trade and other receivables, loans to others, cash and cash equivalents and trade payables in the consolidated statement of financial position.
|
|
Impairment provisions for trade receivables are recognized based on the simplified approach within IFRS 9 using a provision matrix in the determination of the lifetime expected credit losses. During this process the probability of the non-payment of the trade receivables is assessed. This probability is then multiplied by the amount of the expected loss arising from default to determine the lifetime expected credit loss for the trade receivables.
|
F - 52
| I. |
SUMMARY OF THE COMPANY POLICY CONCERNING TRADING POLICIES
|
| II. |
THE USE OF INSIDE INFORMATION IN CONNECTION WITH TRADING IN SECURITIES
|
|
|
A. |
General Rule.
|
|
|
─ |
Significant changes in key performance indicators of the Company,
|
|
|
─ |
Actual, anticipated or targeted earnings and dividends and other financial information,
|
|
|
─ |
New financial, sales and other significant internal business forecasts, or a change in previously released estimates,
|
|
|
─ |
Mergers, business acquisitions or dispositions, or the expansion or curtailment of operations (e.g., entering a new line of business or exiting an existing one),
|
|
|
─ |
Significant cybersecurity or other data protection events affecting the Company’s operations, including any breach of information systems that compromises the functioning of the Company’s information or other systems or results in the
exposure or loss of customer information, in particular personal information,
|
|
|
─ |
Significant new customer contracts or amendments to or terminations of significant existing customer contracts,
|
|
|
─ |
The grant or denial of a significant pending patent application or submission of a new, significant patent application,
|
|
|
─ |
The development and commercialization of a significant new product,
|
|
|
─ |
New equity or debt offerings or significant borrowing,
|
|
|
─ |
Changes in debt ratings, or analyst upgrades or downgrades of the issuer or one of its securities,
|
|
|
─ |
Significant changes in accounting treatment, write-offs or effective tax rate,
|
|
|
─ |
Significant litigation or governmental investigation or the resolution thereof,
|
|
|
─ |
Liquidity problems or impending bankruptcy,
|
|
|
─ |
Changes in auditors or receipt of an auditor notification that the Company may not longer rely on an audit report,
|
|
|
─ |
Changes in control of the Company or changes in the composition of the Board or top management,
|
|
|
─ |
Stock splits or other significant corporate actions, and
|
|
|
─ |
Other significant events affecting the Company’s operations.
|
|
|
B. |
Who Does the Policy Apply To?1
|
|
|
C. |
Other Companies’ Stock.
|
|
|
D. |
Hedging and Derivatives.
|
|
|
E. |
General Guidelines.
|
![]() |
all trades are subject to prior review by the Company’s Chief Executive Officer;
|
![]() |
clearance for all trades must be obtained from the Company’s Chief Executive Officer; and |
![]() |
individuals in the Pre-Clearance Group are also subject to the general restrictions on all employees. |
|
|
F. |
Applicability of U.S. Securities Laws to International Transactions.
|
|
|
A. |
Public Resales – Rule 144.
|
|
|
B. |
Private Resales.
|
|
|
C. |
Restrictions on Purchases of Company Securities.
|
|
|
D. |
Filing Requirements.
|
| 1. |
I have reviewed this annual report on Form 20-F of G. Willi-Food International Ltd.;
|
| 2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
|
| 3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for,
the periods presented in this report;
|
| 4. |
The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and we have:
|
| a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
| b. |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
| c. |
Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and
|
| d. |
Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the
company’s internal control over financial reporting; and
|
| 5. |
The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or
persons performing the equivalent functions):
|
| a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report
financial information; and
|
| b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.
|
|
|
By: /s/ Joseph Williger
Name: Joseph Williger
Title: Chief Executive Officer
|
| 1. |
I have reviewed this annual report on Form 20-F of G. Willi-Food International Ltd.;
|
| 2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
|
| 3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the company as of, and for,
the periods presented in this report;
|
| 4. |
The company’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as
defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the company and we have:
|
| a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the company, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
| b. |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
| c. |
Evaluated the effectiveness of the company’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this
report based on such evaluation; and
|
| d. |
Disclosed in this report any change in the company’s internal control over financial reporting that occurred during the period covered by the annual report that has materially affected, or is reasonably likely to materially affect, the
company’s internal control over financial reporting; and
|
| 5. |
The company’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the company’s auditors and the audit committee of the company’s board of directors (or
persons performing the equivalent functions):
|
| a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the company’s ability to record, process, summarize and report
financial information; and
|
| b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the company’s internal control over financial reporting.
|
|
|
By: /s/ Yitschak Barabi
Name: Yitschak Barabi
Title: Chief Financial Officer
|
|
|
By: /s/ Joseph Williger
Name: Joseph Williger
Title: Acting Chief Executive Officer
|
|
|
By: /s/ Yitschak Barabi
Name: Yitschak Barabi
Title: Chief Financial Officer
|
